CN106947780A - A kind of edit methods of rabbit MSTN genes - Google Patents
A kind of edit methods of rabbit MSTN genes Download PDFInfo
- Publication number
- CN106947780A CN106947780A CN201710191095.3A CN201710191095A CN106947780A CN 106947780 A CN106947780 A CN 106947780A CN 201710191095 A CN201710191095 A CN 201710191095A CN 106947780 A CN106947780 A CN 106947780A
- Authority
- CN
- China
- Prior art keywords
- mstn
- rabbit
- sgrna
- gene
- cas9
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000283973 Oryctolagus cuniculus Species 0.000 title claims abstract description 220
- 108050006583 Growth/differentiation factor 8 Proteins 0.000 title claims abstract description 83
- 238000000034 method Methods 0.000 title claims abstract description 26
- 101150048453 MSTN gene Proteins 0.000 claims abstract description 98
- 108091033409 CRISPR Proteins 0.000 claims abstract description 60
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 claims abstract description 54
- 230000035772 mutation Effects 0.000 claims abstract description 37
- 239000013612 plasmid Substances 0.000 claims abstract description 34
- 238000013518 transcription Methods 0.000 claims abstract description 30
- 230000035897 transcription Effects 0.000 claims abstract description 30
- 238000010354 CRISPR gene editing Methods 0.000 claims abstract description 25
- 238000000338 in vitro Methods 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 10
- 238000009395 breeding Methods 0.000 claims abstract description 6
- 230000001488 breeding effect Effects 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 4
- 235000020997 lean meat Nutrition 0.000 claims abstract description 4
- 238000012239 gene modification Methods 0.000 claims abstract description 3
- 230000005017 genetic modification Effects 0.000 claims abstract description 3
- 235000013617 genetically modified food Nutrition 0.000 claims abstract description 3
- 230000006698 induction Effects 0.000 claims abstract description 3
- 239000002773 nucleotide Substances 0.000 claims description 20
- 125000003729 nucleotide group Chemical group 0.000 claims description 20
- 241000283977 Oryctolagus Species 0.000 claims description 8
- 238000010276 construction Methods 0.000 claims description 7
- 241000894007 species Species 0.000 claims description 5
- 108020004999 messenger RNA Proteins 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 3
- 108700019146 Transgenes Proteins 0.000 claims description 2
- 230000004913 activation Effects 0.000 claims description 2
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 238000012772 sequence design Methods 0.000 claims 1
- 206010064571 Gene mutation Diseases 0.000 abstract description 58
- 108090000623 proteins and genes Proteins 0.000 abstract description 30
- 108091027544 Subgenomic mRNA Proteins 0.000 abstract description 23
- 238000005516 engineering process Methods 0.000 abstract description 23
- 238000010362 genome editing Methods 0.000 abstract description 14
- 238000003209 gene knockout Methods 0.000 abstract description 8
- 238000012217 deletion Methods 0.000 abstract description 6
- 230000037430 deletion Effects 0.000 abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract description 4
- 230000009467 reduction Effects 0.000 abstract description 2
- 101100228739 Danio rerio mstnb gene Proteins 0.000 abstract 2
- 238000012163 sequencing technique Methods 0.000 description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 38
- 235000018417 cysteine Nutrition 0.000 description 35
- 238000000137 annealing Methods 0.000 description 33
- 108020004414 DNA Proteins 0.000 description 32
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 31
- 238000006243 chemical reaction Methods 0.000 description 28
- 239000000243 solution Substances 0.000 description 27
- 239000000047 product Substances 0.000 description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 230000037396 body weight Effects 0.000 description 19
- 230000002441 reversible effect Effects 0.000 description 18
- 238000013461 design Methods 0.000 description 16
- 108090000765 processed proteins & peptides Proteins 0.000 description 16
- 239000012153 distilled water Substances 0.000 description 15
- 235000013601 eggs Nutrition 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 235000001014 amino acid Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 12
- 239000007788 liquid Substances 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 210000003205 muscle Anatomy 0.000 description 12
- 102000006382 Ribonucleases Human genes 0.000 description 11
- 108010083644 Ribonucleases Proteins 0.000 description 11
- 238000011534 incubation Methods 0.000 description 11
- 238000002347 injection Methods 0.000 description 11
- 239000007924 injection Substances 0.000 description 11
- 238000012545 processing Methods 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 10
- 102000002322 Egg Proteins Human genes 0.000 description 9
- 108010056852 Myostatin Proteins 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 238000010367 cloning Methods 0.000 description 9
- 230000003993 interaction Effects 0.000 description 9
- 238000004321 preservation Methods 0.000 description 9
- 102100035102 E3 ubiquitin-protein ligase MYCBP2 Human genes 0.000 description 8
- 108010000912 Egg Proteins Proteins 0.000 description 8
- 238000005119 centrifugation Methods 0.000 description 8
- 210000004681 ovum Anatomy 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 238000001962 electrophoresis Methods 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 230000009182 swimming Effects 0.000 description 7
- 108700028369 Alleles Proteins 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 238000001556 precipitation Methods 0.000 description 6
- 102000004196 processed proteins & peptides Human genes 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 238000010459 TALEN Methods 0.000 description 5
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 description 5
- 108090001012 Transforming Growth Factor beta Proteins 0.000 description 5
- 102000004887 Transforming Growth Factor beta Human genes 0.000 description 5
- 239000007983 Tris buffer Substances 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 210000004899 c-terminal region Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000000295 complement effect Effects 0.000 description 5
- 150000001945 cysteines Chemical class 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 238000004925 denaturation Methods 0.000 description 5
- 230000036425 denaturation Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000000520 microinjection Methods 0.000 description 5
- 238000012856 packing Methods 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 238000004445 quantitative analysis Methods 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- 235000019786 weight gain Nutrition 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 125000003275 alpha amino acid group Chemical group 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 101150038500 cas9 gene Proteins 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 4
- 231100000221 frame shift mutation induction Toxicity 0.000 description 4
- 230000037433 frameshift Effects 0.000 description 4
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 4
- 210000001161 mammalian embryo Anatomy 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 229940066779 peptones Drugs 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000010257 thawing Methods 0.000 description 4
- 239000013598 vector Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 101710163270 Nuclease Proteins 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 108010076504 Protein Sorting Signals Proteins 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 229960000723 ampicillin Drugs 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 230000035800 maturation Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 238000010453 CRISPR/Cas method Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- -1 Given this function Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 239000007836 KH2PO4 Substances 0.000 description 2
- 239000006142 Luria-Bertani Agar Substances 0.000 description 2
- 241001504519 Papio ursinus Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229910000397 disodium phosphate Inorganic materials 0.000 description 2
- 230000005782 double-strand break Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 230000012173 estrus Effects 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000001415 gene therapy Methods 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 239000010390 livzon Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000006780 non-homologous end joining Effects 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 230000000384 rearing effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical group N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 102000012410 DNA Ligases Human genes 0.000 description 1
- 108010061982 DNA Ligases Proteins 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000276489 Merlangius merlangus Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 239000012807 PCR reagent Substances 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 101710124239 Poly(A) polymerase Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 102000003661 Ribonuclease III Human genes 0.000 description 1
- 108010057163 Ribonuclease III Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 101150010487 are gene Proteins 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000011559 double-strand break repair via nonhomologous end joining Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000003198 gene knock in Methods 0.000 description 1
- 238000010363 gene targeting Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 102000057593 human F8 Human genes 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000007233 immunological mechanism Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000016087 ovulation Effects 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013600 plasmid vector Substances 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940047431 recombinate Drugs 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 230000022379 skeletal muscle tissue development Effects 0.000 description 1
- 230000004096 skeletal muscle tissue growth Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001810 trypsinlike Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/107—Rabbit
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Environmental Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Mycology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The present invention relates to gene engineering technology field, more particularly to a kind of rabbit MSTN gene editing methods.This method is in rabbit MSTN locus fixed-point implementation genetic modifications using CRISPR/Cas9;Including being designed according to rabbit MSTN gene target sequences site with homing sequence, the molecular biology material that two-in-one plasmid mstn sgRNA1 and the mstn sgRNA2 of 2 kinds of CRISPR/Cas9, in-vitro transcription go out sgRNA 1, sgRNA 2 and Cas9mRNA and form two kinds of two-in-one compounds being built using homing sequence, the molecular biology material prepare transgenosis rabbit is recycled, the step of the mutation of the extron 4,881 4903 of induction MSTN gene coded sequences the 3rd and 4,796 4818 nucleotide sequences and missing.MSTN gene mutations and gene knockout can be realized using the inventive method, the gene editing rabbit of MSTN expression deletions or reduction is obtained, the present invention can be used for lean meat species rabbit gene editing breeding.
Description
Technical field
The present invention relates to gene engineering technology field, more particularly to a kind of rabbit MSTN genes mediated with CRISPR/Cas9
Edit methods, MSTN gene mutations and gene knockout can be realized using the technology, obtain MSTN expression deletions or the gene of reduction
Rabbit is edited, the present invention can be used for lean meat species rabbit gene editing breeding.
Background technology
Myostatin (myostatin, MSTN) is the negative regulatory factor of Skeletal Muscle Growth development, belongs to conversion life
Long factor-beta (transforming growth factor β, TGF-β) superfamily member, also known as Growth differentiation factor 8 (growth
Differentiation factor 8, GDF-8).MSTN belongs to TGF-β superfamily member, therefore with TGF-β superfamily allusion quotation
The architectural feature of type, includes secreting signal peptide, protease hydrolytic site (the proteolytic processing of N- ends
Site, RSRR) and mature peptide area cysteine structure (cystine knot).The mutation of MSTN genes can cause skeletal muscle
Popularity hyperplasia with it is loose, produce " double flesh symptoms ".MSTN gene structures between the different mammalian species studied at present
Contain 3 extrons and 2 intrones, and ripe peptide amino acid sequence is very conservative, amino acid of differences very little, 3 with
It is interior.The first two extron encodes N-terminal propetide, the 3rd exons coding C-terminal polypeptide jointly.C-terminal polypeptide contains by 9 cysteines
The cysteine knot of composition, the performance of the stabilization and function of the three-dimensional structure of the peering MSTN gene coded proteins of the cysteine rises
To key effect, its structural damage will suppress myostatin signal transduction.Double-muscled phenotype ox in Piemonte ox is exactly
Caused by cysteine (C313Y) mutation.
The MSTN gene coded sequences of the species such as mouse, rat, people, pig, chicken, ox, sheep, baboon and zebra fish occur
Point mutation or frameshift mutation, then typically exhibit the character that muscle mass is dramatically increased.It is many in people, ox, sheep, dog etc. at present
The mutation of abiogenous MSTN genes is found that in kind of species, it has been found that what spontaneous mutation occurred for MSTN genes has Belgium
Blue ox (Belgian blue), Piemonte ox (Piedmontese) etc., show double-muscling shape, and its mutation occurs
exon3。
It was found that MSTN genes contain 3 extrons and 2 intrones in mammal, complete MSTN cDNA include
(mouse and rat are that 376 amino acid are residual to 375 amino acid residues of one ORF (Opening Read Fracture) and coding
Base) nucleotide sequence.MSTN is a kind of secreted polypeptides, has similar characteristic feature to TGF-β superfamily:N-terminal conduct
Secretion signal, has identical amino acid sequence with TGF beta superfamilies;C-terminal has by 4 amino acid (RSRR, Arg-Ser-Arg-
Arg trypsinlike enzyme hydrolytic sites) are constituted;There are 6 cysteine residues formation " cysteine knot " structures in C-terminal, and pass through
Disulfide formation biological activity dimer.Homology of the MSTN maturation peptide sequences in different plant species is very high, mouse, rat,
The homology of people, pig, horse, dog, chicken and turkey is 100%, ox, sheep, the difference of baboon only 1~3 base compared with goat
Not.
MSTN precursor proteins include signal peptide, N-terminal propetide and C-terminal mature peptide, and wherein mature peptide is 109 of C- ends
Amino acid residue.Precursor protein need to be activated through secondary proteolysis, remove signal peptide, and cutting precursor protein is produced before N- ends
Peptide and C- ends polypeptide, C- ends polypeptide are connected to form dimer by disulfide bond, constitute MSTN maturation proteins and secrete to blood circulation,
And with N- ends propetide with non-covalent bond form formation LAP (lantency-associated peptide, 40kDa).Someone uses
Myostatin detection of specific antibody has arrived the presence of ox sarcoblast extract myostatin precursor peptide (52kDa)
And LAP, it was demonstrated that MSTN is synthesized in sarcoblast and is hydrolyzed processing really.
The theme that modification is always the research of bioscience man is oriented to genome, by being dashed forward to MSTN genes
The genetic modifications such as change, missing, knockout, obtain gene mutant animals, on the one hand can construct the animal with " double flesh symptoms "
Model is used for biological study and pathogenic mechanism is studied, and on the other hand can reach the purpose for improving muscle quality and weight, raw
Improved seeds domestic animal of the production with commercialization property.
Genome editor (genome editing) technology is that genome is carried out by insertion, missing or the means replaced
Fixed point transformation, mutation base can be also replaced so as to obtain and can study gene instead of normal gene with mutator with normal gene
Because come the scientific research technology of the function that carries out gene therapy.The principle of this technology is to build an artificial incision enzyme, predetermined
Genomic locations cut off DNA, and the DNA of cut-out can produce mutation in by intracellular DNA repair system repair processes, so as to reach
To the purpose of fixed point modifying gene group.DNA repair systems mainly pass through two kinds of approach DNA plerosis double-strand break (double-
Strand break, DSB), i.e. non-homologous end joining (Non-homologous end joining, NHEJ) and homologous recombination
(homologous recombination, HR).Genome editing technique can realize three kinds by both reparation approach
The purpose of genome manipulation, i.e. gene knockout, gene knock-in and fixed point transgenosis, thus genome editing technique have it is wide
Scientific research and disease treatment prospect.
People always search for simple efficient method and carry out targeting modification to genome.Traditional gene targeting according to
The intracellular abiogenous homologues of Lai Yu recombinate exchange at random, and target practice efficiency is extremely low, and generally only 10-6-10-8, not by
Extensive use.The genome targeting modification technology that nuclease is instructed in recent years is quickly grown.This kind of nuclease is generally by a DNA
Recognize that domain and a non-specific nucleic acid inscribe enzyme domains are constituted, the identification target site of domain specifically recognized by DNA,
Nuclease, which is navigated to, needs the genome area into edlin, then cuts off DNA double chain by non-specific nucleic acid restriction endonuclease, draws
DNA break self-regeneration mechanism is played, so as to trigger the mutation of gene order and promote the generation of homologous recombination.
CRISPR/Cas9 systems are that bacterium resists the invasion of foreign particles or bacteriophage to evolve the one kind come for a long time
Immunologic mechanism, the CRIPSR locus of bacterial host transcribes to form precursor CRIPSRRNA (pre-crRNA), in Cas9 and nucleic acid
Under the assistance of enzyme (RNase III), pre-crRNA is processed to the crRNA of maturation, and outer to the cutting of related Cas9 protein-specifics
Carry out DNA sequence dna, Given this function, CRISPR/Cas9 systems have turned into gene editing technology of new generation.
CRISPR/Cas9 is third generation gene editing technology, has obvious advantage compared with ZFN and TALEN technologies, because of it
Build simply, conveniently, gene editing efficiency high when using, and cost is relatively low, and gene volume has been rapidly become from 2013
The study hotspot for the technology of collecting.Target spot distribution frequencies of the CRISPR/Cas9 in genome is very high, and average every 8 bp just have one
Target spot, TALEN target spot is probably 1/125bp in the distribution frequency of genome, and ZFN distribution frequency is probably 1/
Some genomic locus can not be carried out fixed point editor by 500bp with ZFN and TALENs sometimes, can be with CRISPR/Cas systems
Realize the fixed point editor of the genome.
Cell is identical, in the case of the identical of carrier structure phase Sihe site, CRISPR/Cas9 is in people's iPS cells
Rite-directed mutagenesis efficiency is more than 2 times of TALEN, and CRISPR/Cas9 produces the more efficient of diallele mutation.
CRISPR/Cas systems have more flexibility, because TALEN and ZFN technologies need to redesign to different target spots, and
CRISPR/Cas9 only needs to change 20bp or so sgRNA sequences.But also several sgRNA can be cascaded to same
Multiple sites of one gene are edited simultaneously or multiple different genes are edited simultaneously.
In terms of animals and plants rearing new variety, CRISPR/Cas9 tools have great advantage.Carried by building CRISPR/Cas9
Body, in-vitro transcription obtain RNA after, then microinjection fertilised non-human eggs and obtain target practice animal.Do not deposited during whole practice shooting
In the integration of exogenous DNA, bio-safety problem caused by traditional transgenic technology is also avoided.CRISPR/Cas9 is the mankind
A brand-new thinking is provided in terms of the field of biomedical research such as gene therapy, new drug development.CRISPR/Cas9 technologies exist
The application prospect in the fields such as fundamental research, clinical treatment and farming, animal husbandry and fishery will increasingly have wide, and will produce
Far-reaching influence.
The content of the invention
Present invention aims at a kind of rabbit MSTN gene editings method of offer and its in rabbit MSTN genes exon3 the 372nd,
374 cysteines knock out target site.
Term rabbit MSTN genes refer to that myogenesis suppresses GFP (myostatin) in the present invention.
In order to solve the above problems, this invention takes following technical scheme:
A kind of rabbit MSTN gene editing methods, are to be repaiied using CRISPR/Cas9 in rabbit MSTN locus fixed-point implementation genes
Decorations;Specifically:
(1) according to the new zealand rabbit MSTN gene target sequences as shown in SEQ ID NO.1, for 4881-4903,4796-
4818 nucleotide sequences design sgRNA-1 and sgRNA-2 homing sequence,
(2) 2 kinds of CRISPR/Cas9 are built with the two-in-one plasmid construction kits of YSYCRISPR/Cas9 using homing sequence
They are respectively designated as mstn-sgRNA1 and mstn-sgRNA2 by two-in-one plasmid
(3) mstn-sgRNA1 and mstn-sgRNA2 plasmids respectively as PCR expand sgRNA-1, sgRNA-2 and
Cas9mRNA transcription templates, sgRNA-1, sgRNA-2 and Cas9mRNA are gone out according to transcription templates in-vitro transcription;SgRNA-1 or
SgRNA-2 constitutes activation new zealand rabbit MSTN genes 4881-4903,4796- with Cas9mRNA two-in-one compound respectively
The molecular biology material that 4818 nucleotide sequence mutations and new zealand rabbit MSTN genes are knocked out,
(4) the molecular biology material prepare transgenosis rabbit, the extron of induction MSTN gene coded sequences the 3rd are utilized
The mutation of 4881-4903 and 4796-4818 nucleotide sequence and missing.
In the present invention, the design of homing sequence is as follows:The homologous sequence intercepted and captured in genome target sequence SEQ ID NO.1
(4881-4900 nucleotides) as sgRNA-1 homing sequence, 4901-4903 nucleotides as sgRNA-1 PAM sequences
Homologous sequence (the genome target sequence SEQ ID intercepted and captured in row, genome target sequence SEQ ID NO.1 reverse complementary sequence
NO.1 4796-4815 positions nucleotides reverse complementary sequence) as sgRNA-2 homing sequence, 4816-4818 nucleotides are anti-
To PAM sequence of the complementary series as sgRNA-2:
SgRNA-1 homing sequence:5’-CCATGGTAGTAGACCGCTGT-3’(SEQ ID NO.2)
SgRNA-1 PAM sequences (PAM-1):5’-GGG-3’
SgRNA-2 homing sequence:5’-ATCTTTGTGGGAGTACAGCA-3’(SEQ ID NO.3)
SgRNA-2 PAM sequences (PAM-2):5’-AGG-3’
SgRNA-1 and/or sgRNA-2 and Cas9mRNA preferably presses 1 in step (3) of the present invention:2-5 ratios are used cooperatively.
The gene site-directed knockout techniques of rabbit MSTN of the present invention, the fixed point knockout technique is editor's rabbit MSTN genome target sequences
CRISPR/Cas9 gene Knockouts;
The rabbit MSTN genes target sequence nucleotide sequence, 4881-4903 and 4796-4818 as shown in SEQ ID NO.1
Nucleotides is Design guidance sequence site;
Described CRISPR/Cas9 gene editings instrument is applied to MSTN gene knockout application this patent characteristic materials:
Obtain sgRNA-1, sgRNA-2 using mstn-sgRNA1 and mstn-sgRNA2 plasmids in-vitro transcription, by the sgRNA-1 of acquisition and
SgRNA-2 and Cas9mRNA presses 1:2-5 ratios, which are used cooperatively, is used for embryonated egg microinjection, wherein mstn-sgRNA1, mstn-
SgRNA2, PAM-1, PAM-2, sgRNA-1, sgRNA-2 and Cas9mRNA are this patent characteristic materials.
Applied the invention also discloses methods described in lean meat species transgene rabbit breeding.
The inventive method can effectively induce the 3rd extron of MSTN gene coded sequences 4881-4903 and 4796-4818
The mutation of nucleotide sequence and missing, and produce new zealand rabbit MSTN expression be obstructed and muscle growth strengthen.
Brief description of the drawings
Relative position of Fig. 1 target sites in MSTN genes.
Fig. 2 is the identification of sgRNA plasmids.
Fig. 3 is the sequencing result of sgRNA plasmids.
Fig. 4 is sgRNA and Cas9mRNA electrophoretograms.1:sgRNA1;2:sgRNA2;3:Cas9mRNA;M:λ-
EcoT14digest DNA marker。
Fig. 5 is the kytoplasm microinjection of rabbit embryonated egg.
Fig. 6 is rabbit MSTN gene PCR product electrophoretograms
1:Sterilizing distilled water is used as blank control;2:Normal feminine gender rabbit genome is used as negative control;3~9:M1~M7;
10~18:M8~M16;M:DL2000DNA marker
Fig. 7 is M5 and normal rabbit MSTN gene PCR product Sequencing chromatograms
WT:Normal rabbit Sequencing chromatogram;M5:Diallele is mutated rabbit Sequencing chromatogram.
Fig. 8 is M12 and normal rabbit MSTN gene PCR product Sequencing chromatograms
WT:Normal rabbit Sequencing chromatogram;M12:The negative rabbit Sequencing chromatogram of MSTN mutation.
Fig. 9 is M10 and normal rabbit MSTN gene PCR product Sequencing chromatograms
WT:Normal rabbit Sequencing chromatogram;M10:Diallele mutant cell sample Sequencing chromatogram.
Figure 10 is the build comparison diagram of MSTN mutation rabbits and normal rabbit
WT:Normal rabbit;M3、M5、M6、M10:MSTN gene mutation rabbits.
Figure 11 is MSTN gene mutation rabbit muscle pictures
A、E:M9MSTN is mutated rabbit leg muscle;B:M9MSTN is mutated rabbit shoulder arm and back muscles;C:M9MSTN is mutated rabbit;
D:Normal feminine gender rabbit.
Figure 12 is the 9-14 week old body weight curve maps of MSTN gene mutations rabbit and normal negative rabbit.
Figure 13 is MSTN mutation rabbit Genomic PCR products TA cloning and sequencings results (sgRNA-2).Wherein, target site is
SgRNA-2, "-" represents base deletion, and "+" etc. represents that base increases, and lowercase letter base is replaced, the lowercase of italic
The base increased is represented, " fs " represents that reading frame changes.
Figure 14 is MSTN mutation rabbit Genomic PCR products TA cloning and sequencings results (sgRNA-1).Wherein, target site is
SgRNA-1, "-" represents base deletion, and "+" etc. represents that base increases, and lowercase letter base is replaced, and underlines italic
The base that lowercase letter increases, " fs " represents that reading frame changes.
Embodiment
First, CRISPR/Cas9 plasmid constructions and in-vitro transcription
1. experiment material
1.1 key instruments and equipment
High speed tabletop centrifuge and low-temperature and high-speed centrifuge (German Eppendorf companies);Gene-amplificative instrament (S1000 types,
BIO-RAD companies of the U.S.);DNA electrophoresis apparatuses and electrophoresis tank (DYY-6B types, Nanjing New Campus Biological Technology Institute);Number is solidifying
Glue imaging system (GIS-1000 types, Shanghai Tian Neng Science and Technology Ltd.s);Constant-temperature shaking incubator (IS-RDV1, the smooth Xiang instrument in Nanjing
Equipment Co., Ltd);Water isolation type electro-heating standing-temperature cultivator (PYX-DHS-350-BII types, Shanghai leap medical apparatus and instruments factory);
Electric heating constant temperature tank (DK60 types, the upper grand experimental facilities Co., Ltd of Nereid);(SIM-F124 types, SANYO GS is public for ice machine
Department);Electronic balance (FA1004, Shanghai balance equipment factory);PH detectors (HA405-K2 types, plum Teller-support benefit group Shanghai
Branch company);Automatic dual pure water distiller (SZ-II types, Shanghai Jia Peng Science and Technology Ltd.s);Superclean bench (SJ-CJ-1BQ
Type, Suzhou purifying apparatus instrument factory);- 80 DEG C of ultra low temperature freezers (SANYO GS company);Nucleic acid-protein quantitative analysis instrument (One
DropTM OD-1000+, gene population, Shanghai Yi Tao bio-instruments Co., Ltd);One grade of ultrapure (EPED-20TF
Type, Nanjing Yi Puyida developments in science and technology Co., Ltd).
1.2 molecular biology reagents and kit
The two-in-one plasmid construction kits of YSYCRISPR/Cas9 and Annealing Buffer are purchased from Nanjing Yao along Yu Sheng
Thing Science and Technology Ltd., T4DNA Ligase are purchased from Promega companies, Phanta Super-Fidelity DNA
Polymerase is purchased from purchased from Nanjing Vazyme Biotechnology Co., Ltd., Endo-free Plasmid Mini Kit I
OMEGA (article No.s:D6948-01), tryptone (Tryptone) and yeast extract (Yeast Extract) are public purchased from Oxoid
Department, 2 × Power Taq PCR MasterMix are purchased from BioTeKe (article No.s:PR1700)、ScriptMAX Thermo
T7Transcription Kit (TSK-101) spin bio tech ltd's (article No. purchased from Japan:TSK-101 it is), anti-reverse
Cap analog (ARCA) is purchased from NEB (article No.s:01.NEB.S1411S), poly (A) polymerase is purchased from NEB (article No.s:
01.NEB.M0276S), EasyPure PCR Purification Kit and E.coil Trans5 α competent cells are purchased from north
Jing Quanshijin Bioisystech Co., Ltd (article No.:CD201-01), to be domestic analysis pure for other reagents, is revived respectively purchased from Shanghai
Emerging biological Co., Ltd, Chemical Reagent Co., Ltd., Sinopharm Group etc. are given birth in virtuous chemical reagent Co., Ltd, Nanjing.
The preparation of 1.3 main agents
(1) LB fluid nutrient mediums
5g peptones, 2.5g dusty yeasts and 10g NaCl are weighed, 400mL distilled waters are dissolved in, 500mL is settled to, pH is adjusted extremely
7.5, it is stand-by that autoclaving is cooled to normal temperature.
(2) LB solid mediums
1g peptones, 0.5g dusty yeasts, 1g NaCl and 1g agar powders are weighed, 90mL distilled waters is dissolved in, is settled to 100mL,
Autoclaving, treats that temperature is down to room temperature, adds stand-by after bed board after AMP is mixed.
(3) ampicillin (AMP)
With 4mL sterilizing distilled water dissolving 1g ampicillins, the liquid storage that concentration is 250mg/mL, packing, -20 DEG C of guarantors are made into
Deposit.
(4) plasmid extraction solution
Solution I:Weigh 0.30285g Tris, 0.37224g Na2EDTA and 0.9008g Glucose, plus the double steamings of 90mL
Water dissolves, are settled to 100mL, adjust pH to 8.0, autoclaving, 4 DEG C of preservations.
Solution II:0.2M NaOH and 1%SDS solution is prepared respectively, using being 1:1 volume is mixed.
Solution III:3M NaAc, pH 5.5 is adjusted to glacial acetic acid.
(5) 50 × TAE store liquid
Weigh 242g Tris and 37.2g Na2EDTA·2H2O, measures 57.1mL HAc, plus distilled water is settled to 1L, room
Temperature is preserved.1 is diluted to distilled water when using ×.
(6) 50 × EB store liquid
100mL distilled waters dissolve 1g ethidium bromide powder, be made into concentration be 10mg/mL liquid storage, 4 DEG C preservation, the used time with
Distilled water is diluted to 1 ×.(7) RNaseA solution
RNaseA is dissolved in 10mmol/L Tris and 15mmol/LNaCl mixed liquors, and compound concentration is 10mg/mL, 100 DEG C
Boil 15min, -20 DEG C of preservations.
(8) DEPC handles water:Pure water meter prepares ultra-pure water, then double steamings.It is water-soluble that 0.1%DEPC is prepared with the ultra-pure water of double steamings
Liquid, fierce shaking, until bottom of bottle can't see oily particle, 37 DEG C of incubator overnights, second day, 121 DEG C of high pressure 40min, which take out, to be put in
Normal temperature is cooled in super-clean bench.In the dactylethrae that no RNase 2mL is dispensed into the pipette tips without RNase, -20 DEG C freeze.
(9) 70% ethanol without RNase:Take 3mL DEPC water+7mL absolute ethyl alcohol.With the pipette tips without RNase
In the dactylethrae for being dispensed into no RNase 2mL, -20 DEG C freeze.
2. experimental method
2.1mstn-sgRNA1 and mstn-sgRNA2 plasmid constructions and identification
Mstn-sgRNA1 and mstn-sgRNA2 matter is built using the two-in-one plasmid construction kits of YSYCRISPR/Cas9
Grain, using the plasmid as template, and the primer amplification sgRNA-1 and sgRNA-2 that Nanjing Yao Shunyu bio tech ltd is provided
Transcription templates.(primer 1, primer 2, primer 3, primer 4 are shown in Table 2-1)
Table 2-1 primer information
2.1.1 the single-stranded annealing primers of sgRNA are designed
Corresponding sgRNA templates are designed for the sgRNA-1 and sgRNA-2 of rabbit MSTN genes homing sequence, form is
gNNNNNNNNNNNNNNNNNNN[NGG]." g " is the first nucleotides of sgRNA templates;N is the specific nucleotide of target gene.
NGG is PAM sequences, and it must be present on genomic DNA but is not present on sgRNA template DNA sequences.If 20 nucleotides
SgRNA templates first place be not " g ", please add " g " in first place, now a length of 21 nucleotides of template.
According to the corresponding annealing primer of sgRNA stencil designs, by primer, Synesis Company synthesizes.
Form is:
Positive single-stranded annealing primer:TATAgNNNNNNNNNNNNNNNNNNN
Reverse single-stranded annealing primer:AAACNNNNNNNNNNNNNNNNNNNc
It is the reverse of gNNNNNNNNNNNNNNNNNNN to note reverse single-stranded annealing primer NNNNNNNNNNNNNNNNNNNc
Complementary series;
If the sgRNA first places of 20 nucleotides are " g ", N number is 19, and forward and reverse single-stranded annealing primer is 24
Nucleotides is long;If it is not " g " that the sgRNA of 20 nucleotides is the first, above adding one " g ", then N number is 20, now
Forward and reverse single-stranded annealing primer is that 25 nucleotides are long.
2.1.2 the single-stranded annealing primers of sgRNA are synthesized
SgRNA-1 single-stranded annealing primer (5 ' -3 '):
Positive single-stranded annealing primer:TATAgCCATGGTAGTAGACCGCTGT(SEQ ID NO.8)
Reverse single-stranded annealing primer:AAACACAGCGGTCTACTACCATGGc(SEQ ID NO.9)
SgRNA-2 single-stranded annealing primer (5 ' -3 '):
Positive single-stranded annealing primer:TATAgATCTTTGTGGGAGTACAGCA(SEQ ID NO.10)
Reverse single-stranded annealing primer:AAACTGCTGTACTCCCACAAAGATc(SEQ ID NO.11)
2.1.3 forward and reverse two primers are annealed
(1) single-stranded annealing primer is dissolved in ultra-pure water, to 100 μM
(2) 10 μ L reaction systems, reaction system such as table 1-1 are separately constituted by following formulas in 2 PCR pipes.
Table 1-1 primer annealing systems
(3) reaction system is mixed, it is then quick to centrifuge solution centrifugal to PCR bottoms.
(4) system after mixing is put into PCR instrument to be reacted, 95 DEG C be incubated 5min after, with 1.5 DEG C per minute gradually from
95 DEG C are down to 22 DEG C.
2.1.4 annealed product is connected with the two-in-one plasmids of YSYCRI SPR/Cas9 linearized
(1) by 10 μ L reaction systems of following formula compositions, reaction system such as table 1-2 in PCR pipe.Table 1-2DNA connectors
System
(2) mix, then quickly centrifuge mixed liquor to PCR pipe bottom.
(3) 16 DEG C are stayed overnight or incubation at room temperature 30min.
(4) Trans5 α competence Escherichia coli are taken out from -80 DEG C of refrigerators, are immediately placed on ice.
(5) after after competent cell defrosting, the connection product that 50 μ L competent cells are gently added in 10 μ L (1) is i.e.
Can, it is not necessary to which mixing, ice bath 30min are played in suction.
(6) 42 DEG C of water-bath heat shock 45s, after be immediately placed on and be incubated 2min on ice, centrifuge tube should not be rocked.
(7) 100 μ L LB culture mediums (antibiotic-free, room temperature) are added, (are covered tightly in 37 DEG C of constant-temperature table culture 40min~1h
Lid).
(8) take all bacterium solutions to be spread evenly across on the LB agar plates containing 50 μ g/mL ampicillins, be inverted in incubated
37 DEG C of overnight incubations (14~18h) in case.
2.1.5 the bacterium colony PCR identifications of conversion flat board
(1) 3 1.5mL EP pipes are prepared, often pipe adds the LB liquid that 20 μ l contain 50 μ g/mL ammonia benzyls.
(2) pipette tips treated with autoclaving are directly placed into ready EP from picking monoclonal on LB agar plates and managed
In.3 clones of picking on each plate.
(3) cover tightly after lid, vortex oscillation EP pipes.
(4) prepare 3 0.2mL PCR pipe, prepare 10 μ LPCR reaction systems respectively as follows in each pipe,
It is loaded by following system, reaction system such as table 1-3.
Table 1-3 PCR systems
PCR reaction conditions:95 DEG C of pre-degeneration 2min;94 DEG C of denaturation 30sec, 56 DEG C of annealing 30sec, 72 DEG C of extension 30sec,
Repeat 35 circulations;72 DEG C re-extend 10min, 20 DEG C of 5min;Terminate reaction.
113bp band should occur in (5) 2% agarose gel electrophoresis, positive colony.
2.1.6 bacterium solution is sequenced
The bacterium solution that warp let-off PCR checkings have positive band goes sequencing (sequencing primer select primer 3), confirm sgRNA-1 and
SgRNA-2 homing sequence (removing PAM sites) and frame sequence is really in plasmid;Meanwhile, same bacterium is seeded in
In LB pipes of the 10mL containing ampicillin, shake bacterium under the conditions of 37 DEG C and stay overnight, for follow-up a small amount of extraction plasmids and preservation strain
With will confirm that homing sequence (remove PAM sites) and the plasmid of frame sequence containing sgRNA-1 and sgRNA-2 are named respectively
For mstn-sgRNA1 and mstn-sgRNA2.
Frame sequence:gttttagagctagaaatagcaagttaaaataaggctagtccgttatcaacttgaaaaagt
Ggcaccgagtcggtgctttttt (SEQ ID NO.12) 2.1.7mstn-sgRNA1 and mstn-sgRNA2 DNAs it is small
It is prepared by amount
Positive plasmid is extracted using OMEGA small extraction reagent kit, operating procedure is as follows:
(1) 1.5~5ml bacterium solutions are centrifuged 1min, operated at room temperature with 1000g/min.
(2) supernatant is removed, 250 μ L SolutionI (in advance plus good RNase A), and fully resuspended precipitation is added.
(3) 250 μ L Solution II are added into re-suspension liquid and are softly mixed makes bacterium fully crack.
(4) the Buffer N3 of 125 μ L ice precoolings are added into mixed liquor and are softly fully mixed until there is white flock
Mixture.
(5) 4 DEG C or room temperature centrifuge 10min with 12000g/min.
(6) carefully supernatant is drawn into 1.5mL centrifuge tubes, tries not to be drawn onto precipitation.Add 0.1 times of volume
ETR Solution.It is reverse to mix 7~8 times, it is placed in 10min on ice.
(7) solution in (6) is put in 42 DEG C of incubation 5min.3min is centrifuged with 12000g/min under the conditions of 25 DEG C.
(8) Aspirate supernatant adds the absolute ethyl alcohol of 0.5 times of volume into new 1.5mL centrifuge tubes, and gently overturns mixed
Even 6~7 times.And it is stored at room temperature 1~2min.
(9) draw (8) in the μ L of mixed liquor 700 into DNA columns, at room temperature under with 10000g/min centrifuge 1min.
(10) discard efflux, 500 μ L Buffer HB added into column, at room temperature under centrifuged with 10000g/min
1min。
(11) efflux is discarded, 700 μ L DNA Wash Buffer, 10000g/min centrifugations are added into column
1min, discards efflux.
(12) step (11) is repeated.
(13) 2min is centrifuged from column (>=13000g/min) so that maximal rate is empty.
(14) column is put into 1.5mL centrifuge tubes, adds the Elution Buffer of 30~50 μ L endotoxin-free
Or water, 1min is centrifuged with maximum velocity centrifugation column (>=13000g/min).
2.2mstn-sgRNA1 and mstn-sgRNA2 plasmid in-vitro transcriptions
2.2.1 sgRNA and cas9 transcription templates are prepared
(1) sgRNA1 transcription templates are prepared:By 50 μ L PCR reaction systems of following formula compositions, reactant in PCR pipe
System such as table 1-4.
Table 1-4 PCR systems
PCR reaction conditions:95 DEG C of pre-degeneration 30sec;95 DEG C of denaturation 5sec, 52 DEG C of annealing 10sec, 72 DEG C of extension 5sec,
Repeat 30 circulations;72 DEG C re-extend 5min;Terminate reaction.
(2) sgRNA2 transcription templates are prepared:Related PCR reagent is Vazyme Phanta Super-Fidelity DNA
Polymerase, by 50 μ L PCR reaction systems of following formula compositions, reaction system such as table 1-5 in PCR pipe.
Table 1-5 PCR systems
PCR reaction conditions:95 DEG C of pre-degeneration 30sec;95 DEG C of denaturation 5sec, 52 DEG C of annealing 10sec, 72 DEG C of extension 5sec,
Repeat 30 circulations;72 DEG C re-extend 5min;Terminate reaction.
(3) cas9 transcription templates are prepared:By 50 μ L PCR reaction systems of following formula compositions, reaction system in PCR pipe
Such as table 1-6.
Table 1-6 PCR systems
PCR reaction conditions:95 DEG C of pre-degeneration 30sec;95 DEG C of denaturation 10sec, 56 DEG C of annealing 15sec, 72 DEG C of extensions
68sec, repeats 34 circulations;72 DEG C re-extend 5min;Terminate reaction.
2.2.2 sgRNA transcription templates and cas9 transcription templates are purified
SgRNA1, sgRNA2 and cas9 transcription templates are purified respectively with TRANSGEN PCR purification kits:
(1) 100 μ L PCR primers add the BB of 5 times of volumes, and mixing to add in centrifugal column (can stand 1min), 10000g/
Min, centrifuges 1min, discards efflux.
(2) 650 μ L WB, 10000g/min are added, 1min is centrifuged, discards efflux.(being repeated once)
(3) 10000g/min, centrifuges 1min, removes the WB of residual, and volatilization alcohol of uncapping.
(4) DEPC that 30~50 μ L of 60~70 DEG C of preheatings are added to centrifugal column handles water, is stored at room temperature 1min,
10000g/min, centrifuges 1min.(5) nucleic acid-protein quantitative analysis instrument surveys purified pcr product solubility and OD values, dispenses after purification
PCR primer, 5 μ L/ pipes, -20 DEG C freeze.2.3 PCR primer using in 2.2.2 is template transcript mRNA
2.3.1 transcribe and purify sgRNA
(1) phase on ice in defrosting ScriptMAX Thermo T7Transcription Kit (TSK-101) kit
Liquid is closed, and table 1-7 systems are loaded, and are added and fully mix sample after sample, 40 DEG C of incubation 4h.
After incubation terminates, 1 μ L TURBO DNase are added, 37 DEG C of incubation 15min after fully mixing.Table 1-7 in-vitro transcriptions
System
(2) transcription product is purified:
30 μ L Nuclear-free water and 30 μ L LiCl solution are added in a, above-mentioned transcription product, are mixed, -20 DEG C
Place at least 30min;
B, 4 DEG C, 16000g/min, centrifugation 15min;
C, except supernatant, the ethanol of 1mL 70% (no RNase water is prepared) cleaning precipitation, 16000g/min centrifuges 15min;
D, 70% ethanol of removing, super-clean bench place 5~10min, no RNase water dissolves precipitation;
E, nucleic acid-protein quantitative analysis instrument survey solubility, and no RNase water is diluted to 20ng/ μ L, are distributed into 5 μ L/ pipes, -80 DEG C
Freeze standby.
2.3.2 transcribe and purify cas9mRNA
(1) phase on ice in defrosting ScriptMAX Thermo T7Transcription Kit (TSK-101) kit
Liquid is closed, and by table 1-8 systems sample-adding, adds and fully mix sample after sample, 40 DEG C of incubation 4h
Table 1-8 in-vitro transcription systems
After incubation terminates, 1 μ L TURBO DNase are added, 37 DEG C of incubation 15min after fully mixing.
(2) cas9mRNA adds poly A.Related reagent in defrosting E.coil polymerase kits on ice, by table
1-9 systems are loaded, and are added and fully mix sample after sample, 37 DEG C of incubation 45min.
Table 1-9 adds polyA systems
(3) transcription product is purified:
40 μ L Nuclear-free water and 120 μ L are added in a, the transcription product that incubation terminates into 2.3.2 (2)
LiCl solution, is mixed, -20 DEG C of placement at least 30min;
B, 4 DEG C, 13000g/min, centrifugation 15min;
C, except supernatant, the ethanol of 1mL 70% (no RNase water is prepared) cleaning precipitation, 13000g/min centrifuges 15min;
D, 70% ethanol of removing, super-clean bench place 5~10min, no RNase water dissolves precipitation;
E, nucleic acid-protein quantitative analysis instrument survey solubility, and no RNase water is diluted to 80ng/ μ L, are distributed into 5 μ L/ pipes, -80 DEG C
Freeze standby.
3. design requirement and identification and analysis
3.1MSTN gene knockouts site design requirement
The relative position such as Fig. 1, sgRNA of target site on the extron of rabbit MSTN genes the 3rd homing sequence are generally
20bp, PAM sequence (NGG), this be design target sequence necessary to.Homing sequence to the sgRNA-1 and sgRNA-2 of design adds
Plus cohesive end (TATAg), you can the forward and reverse single-stranded annealing primers of sgRNA-1 and sgRNA-2 are synthesized, form is:
Positive single-stranded annealing primer:TATAgNNNNNNNNNNNNNNNNNNN
Reverse single-stranded annealing primer:AAACNNNNNNNNNNNNNNNNNNNc
It is the reverse of gNNNNNNNNNNNNNNNNNNN to note reverse single-stranded annealing primer NNNNNNNNNNNNNNNNNNNc
Complementary series;
SgRNA-1 single-stranded annealing primer (5 ' -3 '):
Positive single-stranded annealing primer:TATAgCCATGGTAGTAGACCGCTGT
Reverse single-stranded annealing primer:AAACACAGCGGTCTACTACCATGGc
SgRNA-2 single-stranded annealing primer (5 ' -3 '):
Positive single-stranded annealing primer:TATAgATCTTTGTGGGAGTACAGCA
Reverse single-stranded annealing primer:AAACTGCTGTACTCCCACAAAGATc
3.2mstn-sgRNA1 and mstn-sgRNA2 plasmid constructions and identification
Synthesize sgRNA-1, after sgRNA-2 forward and reverse single-stranded annealing primer, anneal respectively, annealed product with
The two-in-one plasmid vector connections of YSYCRISPR/Cas9, are built into the two-in-one plasmids of CRISPR/Cas9, connection product conversion impression
State, is coated with ammonia benzyl agar plate, picking monoclonal bacterium colony is thalline PCR after growth overnight, and 113bp sizes occurs in PCR primer electrophoresis
Band is positive colony (such as Fig. 1-2).To further determine that the correctness of the two-in-one plasmids of CRISPR/Cas9, it will expand
Go out the bacterium solution sequencing of positive band, carry out sequence alignment, identify the two-in-one plasmids of CRISPR/Cas9 correctly connected
Shown by Fig. 2,113bp positive band occur in 1,2,3 and 6 swimming lanes, and bacterium solution is sequenced respectively, then with rabbit
The designed sgRNA-1 and sgRNA-2 of MSTN genes homing sequence are compared, as a result consistent, such as Fig. 3.Finally successfully obtain
Can recognize the plasmid of rabbit MSTN gene sgRNA-1 and sgRNA-2 target sites, they are named respectively mstn-sgRNA1 and
mstn-sgRNA2。
4.mstn-sgRNA1 and mstn-sgRNA2 plasmid in-vitro transcriptions
With mstn-sgRNA1, mstn-sgRNA2 plasmids are template PCR amplifications sgRNA-1, sgRNA-2 (primer 3 and primer
4) and Cas9mRNA (primer 1 and primer 2) transcription templates, its size is respectively 224bp, 224bp and 4343bp.Produced with PCR
Thing is transcription templates, in the presence of t7 rna polymerase, in-vitro transcription sgRNA-1, sgRNA-2 and Cas9mRNA.Wherein
Cas9mRNA needs to translate into Cas9 albumen in the cell, therefore need to promote cell plus ARCA caps and poly A structures in vitro
It is interior to translate and prevent that mRNA from degrading.Show that sgRNA-1, sgRNA-2,3 swimming lane that 1,2 swimming lanes are in-vitro transcription are external by Fig. 4
Transcribe and add ARCA caps and the Cas9mRNA of poly A structures.
2nd, the preparation of MSTN gene mutations rabbit
1. material
1.1 experimental animals
Experimental animal used by this patent can be regular grade NZw or other kind rabbit, doe 6~August age,
3.5~5kg of body weight, the monthly age of breeding male rabbit 10~12.Rearing conditions:18~25 DEG C of room temperature, humidity 40%~50%, ventilation are good,
Feeding in one day twice, adds 80g pellets, and provide the drinking water of abundance every time.
1.2 key instruments
Stereomicroscope (Xiamen company of Mike Audi;TMS, NIKON, Japan);Fluorescence inverted microscope and micromanipulation
Instrument (Leica companies, Germany;Eppendorf TransferMan NK2 companies;IX-71, Olympus, Japan);Draw pin instrument
(MODEL P-97,INSTRUMENT,USA);CO2Incubator (MCO-18M ThermoForma);Gene-amplificative instrament (S1000
Type, BIO-RAD companies of the U.S.);Superclean bench (SJ-CJ-1BQ types, Suzhou purifying apparatus instrument factory);DNA electrophoresis apparatuses and electricity
Swimming groove (DYY-6B types, Nanjing New Campus Biological Technology Institute);Digital gel imaging instrument (GIS-1000 types, Shanghai Tian Neng sections
Skill Co., Ltd);Ice machine (SIM-F124 types, SANYO GS company);Water isolation type electro-heating standing-temperature cultivator (PYX-DHS-350-
BII types, Shanghai leap medical apparatus and instruments factory);Electronic balance (FA1604, Shanghai precision balance);PH detectors (HA405-K2 types,
Plum Teller-Shanghai branch company of support benefit group);Electric constant-temp drying box (MICRO-4HYBAID);Table-type high-speed refrigerated centrifuge
(Biofuge companies, Germany;Eppendorf companies, Germany);(80-2 types, Shanghai Medical apparatus is limited for low speed desk centrifuge
Operating theater instruments factory of company);One grade of ultrapure (EPED-20TF types, Nanjing Yi Puyida developments in science and technology Co., Ltd);Electricity
Hot Water Tank with Temp.-controlled (DK600 types, the upper grand experimental facilities Co., Ltd of Nereid);Pipettor (Eppendorf companies, Germany);Commonly
Refrigerator (Qingdao company of Haier);- 80 DEG C of ultra low temperature freezers (SANYO GS company);(IS-RDV1, Nanjing is smooth for constant-temperature shaking incubator
Xiang instrument and equipment Co., Ltd);Nucleic acid-protein quantitative analysis instrument (One DropTM OD-1000+, gene population, Shanghai
Yi Tao bio-instruments Co., Ltd);Ultrasonic cleaner (KQ-300DE types, Kunshan Ultrasonic Instruments Co., Ltd.).
1.3 main equipment
Toy routine Shelf for keeing, capillary glass tube (DCG-10, DC-10 type, Narishige, Japan), syringe, silicon
Change plate and slide, self-control ovum shifting tube and suction pipe, Embryo Culture side's cup connects ovum cup etc., platform balance.
1.4 main agents and medicine
The cell tests such as NaH2CO3, KCl, KH2PO4, K2HPO4, Na2HPO4, EDTANa2, NaCl level reagent (is purchased from
Sigma companies);M16 (M7292-100ML, Sigma company);M2 (M7167-100ML, Sigma company);FSH
(110044629, Ningbo Sansheng Pharmaceutical Co., Ltd.);HCG (091217B, Livzon Pharmaceutical Factory, Livzon Group);
Penicillin-streptomycin (PS) and Fetal Bovine Serum (FBS) is purchased from HyClone companies;pGEM-T
Easy Vector (A1360, Promega) T-4ligase (is purchased from Promaga companies);Archaeal dna polymerase (DNA
Polymerase), dNTP, DNA Marker (DL2000) are purchased from precious bioengineering (Dalian) Co., Ltd, other in experiment
It is pure that reagent is domestic analysis, gives birth to emerging biological Co., Ltd purchased from Nanjing respectively, the Shanghai biological Co., Ltd of life work, and Nanjing promise is only
Biological Co., Ltd is praised, etc..
1.5 main agents are prepared
(1) egg liquid
Weigh 10g NaCl, 0.25g KH2PO4, 0.25g KCl and 1.44g Na2HPO4, plus after the dissolving of 900 distilled waters calmly
Hold to 1000mL, autoclaving, dispense 50mL/ bottles, -4 DEG C of preservations.
(2) Tissue lysates
Weigh 2.4228g Tris-Base, 7.444g EDTANa2After 1g SDS, plus 150mL sterilizing distilled water dissolvings
It is settled to 200mL, autoclaving, packing, -20 DEG C of preservations.
(3) LB fluid nutrient mediums
5g peptones, 2.5g dusty yeasts and 10g NaCl are weighed, 400mL distilled waters are dissolved in, 500mL is settled to, pH is adjusted extremely
7.5, it is stand-by that autoclaving is cooled to normal temperature.
(4) LB solid mediums
1g peptones, 0.5g dusty yeasts, 1g NaCl and 1g agar powders are weighed, 90mL distilled waters is dissolved in, is settled to 100mL,
Autoclaving, treats that temperature is down to room temperature, adds stand-by after bed board after AMP is mixed.
(5) ampicillin (AMP)
With 4ml sterilizing distilled water dissolving 1g ampicillins, the liquid storage that concentration is 250mg/mL, packing, -20 DEG C of guarantors are made into
Deposit.
(6) X-gal solution
Weigh 20mg X-gal powder and be added to the mixing of 1mL dimethyl formamide solutions, packing, lucifuge is preserved in -20 DEG C.
(7) IPTG solution
2g IPTG powder is weighed, distilled water, constant volume to 10mL is added.Packing, lucifuge is in -20 DEG C of preservations.
(8) plasmid extraction solution
Solution I:Weigh 0.30285g Tris, 0.37224g EDTANa2With 0.9008g Glucose, plus the double steamings of 90mL
Water dissolves, are settled to 100mL, adjust pH to 8.0, autoclaving, 4 DEG C of preservations.
Solution II:0.2M NaOH and 1%SDS solution is prepared respectively, using being 1:1 volume is mixed.
Solution III:3M NaAc, pH5.5 is adjusted to glacial acetic acid.
2. method
2.1 donor rabbits superfecundation are with supplying acceptor estrus synchronization
Female rabbit of every group of experiment picking two only non-heat is as super row's donor rabbits, female rabbit vulva whiting, slightly dry it is believed that
Non- heat.Using continuous 6 dose of FSH diminishing methods to often injecting FSH only for the leg muscle of the female rabbit of body, FSH total amount is
60IU, morning and afternoon respectively injection once (8:00 and 20:00), successively decrease and be followed successively by 15IU, 15IU, 10IU, 10IU, 5IU, 5IU.Most
Afterwards after shot FSH 12h, every donor rabbits auricular vein injects 100IU hCG, is bred therewith with normal buck.
The female rabbit 2~4 of acceptor is selected after the completion of donor rabbits breeding immediately and is only used as acceptor, good female rabbit moves as acceptor for heat
Plant pregnancy rate high.To ensure to inject 100IUhCG with donor rabbits synchronization of estrus, every recipient rabbits auricular vein, be used as recipient rabbits.
Nature enemy will be done for recipient rabbits.
2.2 reclaim donor rabbits embryonated egg
18~20h after donor rabbits injection hCG, conventional fimbriae tubae portion reclaims embryonated egg, picked under stereomicroscope by
Smart ovum, counts and moves in M16 nutrient solutions, is placed in 38 DEG C, 5%CO2, cultivates in saturated humidity incubator.
2.3mRNA microinjection rabbit embryonated eggs
(1) injection needle (10~15 μm of diameter, 0.5 μm~1.5 μm of pin mouthful at 50 μm away from needle point) is prepared, and preparation is held
Ovum fixes pin (120~150 μm of external diameter, 10~20 μm of internal diameter).
(2) cas9mRNA and sgRNA dispense is taken out from -80 DEG C of ultra low temperature freezers, is mixed in equal volume, cas9mRNA with
SgRNA end solubility is respectively 40ng/ μ L and 10ng/ μ L.
(3) in the good injection needle of inverted microscope over-assemble and fixed pin, with the siphon pipe without RNAse draw cas9mRNA and
In sgRNA mRNA mixtures injection injection needle, focal length is then debugged, makes injection needle clearly visible in the visual field.
(4) embryonated egg is moved in M2 operation drops, adjustment microscope is until that can be clearly observed embryonated egg in the visual field.
(5) injection needle and fixed pin are gently fallen, the focusing of alignment ovum surface is basic in same plane with embryonated egg.
(6) fixed pin gently fixes embryonated egg, and the focusing of injection tip alignment ovum center makes needle point high-visible,
Then carefully it is pierced into the kytoplasm of embryonated egg.
(7) syringe applies pressure slightly, it was observed that injection needle point have liquid outflow, that is, complete once it is complete penetrate, repeat
The process is finished up to the injection of all embryonated eggs, such as Fig. 5.
2.4 embryo transfers
Need to observe the survival rate of microinjection ovum before conventional embryo transfer, transplanting, reject dead ovum and ovum out of order.It is defeated
Whether oviduct and ovary, observation ovary have ovulation point or folliculus i.e. portable.Embryo moves into fallopian tubal, in ampulla of uterine tube
Inject embryonated egg.Generally, female rabbit pregnancy 30 days or so can spontaneous labor, conventional mother's rabbit postnatal care and young rabbit lactation.
3. technique effect judges and detection in Gene Mutation
3.1MSTN detection in Gene Mutation
3.1.1 the extraction of rabbit genome
(1) the sterile clip have sharp ears tissue of young rabbit of 2~3 weeks after being born, and clip normal rabbit ear tissue, are put into dactylethrae
And shred, add 750 μ L
Tissue lysates and 7.5 μ L Proteinase Ks (25mg/mL), 55 DEG C of rotation digestion, until visually observing less than tissue block
Untill.
(2) 12000rpm is centrifuged, 10min, is taken sticky supernatant in another clean dactylethrae, is added 750 μ L phenol, overturns mixed
It is even, 12000rpm
Centrifugation, 10min.
(3) supernatant is taken in another clean dactylethrae.
(4) 750 μ L 1 are added:1 phenol:Chloroform mixture, overturns and mixes, 12000rpm centrifugations, 10min.
(5) supernatant is taken in another clean dactylethrae, 750 μ L chloroforms are added, and is overturned and is mixed, 12000rpm centrifugations,
10min。
(6) supernatant is taken in another clean dactylethrae, the absolute ethyl alcohol 1mL of precooling is added, overturns and mixes, and precipitates genome
DNA (white flock).(7) picking white DNA agglomerates, add the ethanol of 1mL 70% and fully wash, 12000rpm centrifugations, 5min.
(8) supernatant is abandoned, deposit is through 37 DEG C of drying.
(9) 20~50 μ L sterilizing distilled water dissolvings are added according to the amount of genome, -20 DEG C save backup.
3.1.2 the detection of son rabbit MSTN gene PCRs and sequencing
The MSTN gene knockout situations of rabbit are reliably detected for convenience, and application software Primer5.0 is directed to rabbit MSTN bases
Because primer is designed in mutational site, primer information is shown in Table 2-1.
Table 2-1 primer information
PCR reaction systems are prepared by table 2-2,
Table 2-2 PCR systems
PCR reaction conditions:95 DEG C of pre-degeneration 5min;94 DEG C of denaturation 50sec, 48 DEG C of annealing 45sec, 72 DEG C of extension 1min,
Totally 33 circulations;72 DEG C re-extend 10min, 4 DEG C of preservations.
5 μ LPCR products are taken in 1.0% agarose gel electrophoresis, preliminary judgement son's rabbit MSTN gene mutation situations.
In order to which whether the MSTN genes for further verifying the young rabbit obtained undergo mutation, PCR primer is subjected to sequence survey
It is fixed, and compared using DNAStar sequence analysis softwares with amplification template standard sequence, with Chromas softwares observation sequencing peak
Figure set peak situation.
3.1.3 young rabbit MSTN gene PCR amplified productions TA is cloned
For the mutation type of identification of M STN positive gene mutation rabbits, PCR primer sequencing result is further shown as MSTN
Gene mutation PCR primer is connected with pGEM-T cloning vectors.Purify examination with TRANSGEN PCR before connection pGEM-T cloning vectors
Agent box purified pcr product.Purify the calculating that the PCR primer obtained is measured as follows with pGEM-T cloning vectors:
According to connection enzyme system explanation, reaction system is prepared, reaction system is shown in Table 2-3:
Table 2-3 DNA linked systems
Reaction condition:4 DEG C of connections are stayed overnight.
The benefit and production performance that 3.2 the art of this patent are produced, which are improved, to be judged
3.2.1 evaluation method
Weigh the body weight of experimental group rabbit (M1~M11) and normal negative rabbit (WT1~WT10) day by day from 9 week old.Carry out
Record.
Calculate male rabbit (including the male rabbit of MSTN mutation and normal cloudy of 9~14 week old respectively with the statistical softwares of SPSS 20.0
Property male rabbit), doe (including MSTN mutation does and normal negative doe) and MSTN be mutated the body of rabbit (including male rabbit and doe)
Weight Zhou Zengliang carries out systematic variance analysis and carries out DuncanShi methods progress Multiple range test, with P<0.05 is that the significance of difference judges
Standard.
Initial experimental design purpose is to prepare the MSTN gene mutation rabbits with double-muscled phenotype.In order to make mutation as far as possible
MSTN genes drop or loss of biological activity, and cause to produce inhibitory action to the functions of MSTN genes as far as possible, simultaneously
In view of being removed before 266 amino acid functions at N- ends, it is to avoid 266 amino acid of the design in excision will be mutated
It is interior and cause to occur situation of the mature peptide function without influence, therefore by the design of MSTN genes target site in mature peptide region.Examine
Consider later stage young rabbit MSTN detection in Gene Mutation situations, with DNAStar software analysis rabbit MSTN gene mature peptides area restriction enzyme site,
Because conventional restriction enzyme site is rare, and design CRISPR/Cas9 target sites need PAM sequences, therefore do not look for and be suitable for the later stage
The target site of the conventional restriction enzyme site of abrupt climatic change so that the Preliminary detection in later stage can only use gene sequencing means.
3.2.2 this technology obtains the uniformity of effect and design
Normal rabbit MSTN genes are expanded with the pair of primers (CAS9SG123-1 and CAS9SG123-2) of design, obtained
The purpose band size arrived is 498bp, and equally obtained to this experiment 16 son's rabbit MSTN genes are expanded, then 1%
Gel electrophoresis, EB is dyed, and observation of being taken pictures under ultraviolet light, experimental result is shown in Fig. 6.If MSTN gene delections or to increase band larger,
It can be distinguished with the contrast of normal band, can the young rabbit MSTN gene mutation situations of preliminary judgement.For lacking or increasing bar
The situation of base replacement only occurs for band, is only reflected by sequencing after follow-up PCR primer sequencing or PCR primer TA clones
It is fixed.Observe MSTN gene PCR electrophoresis graph discoveries, the 6th, 8, the electrophoretic band of 12 swimming lanes be significantly less than the normal control of the 2nd swimming lane
Band, remaining swimming lane stripe size, which changes, visually to be recognized, can only subsequent gene sequencing judgement.Have 3 in the young rabbit obtained
Individual young rabbit can preliminary judgement be the success of MSTN gene knockouts, rabbit gene mutation situation is obtained by further identification, by the 16 of acquisition
The only PCR primer sequencing of young rabbit and normal control rabbit.
Result is shown after the completion of the MSTN Genomic PCR products sequencing of 16 young rabbits and normal rabbit:M1~M9, M11 and M13
There are a variety of bases in sgRNA-1 location proximates in~M16 PCR primer sequencing peak figure display set peak, M1~M7 Sequencing chromatogram
There are a variety of base signals in sgRNA-2 location proximates in signal, M8~M9, M11 and M13~M16 Sequencing chromatogram, show M1~
There is mutation in the MSTN genes of M9, M11 and M13~M16 rabbits, be MSTN gene mutation rabbits.Such as Fig. 7,8,9.
There is set peak structure in M5 rabbit PCR Sequencing chromatograms, and the PCR Sequencing chromatograms contrast with normal rabbit finds that multiple bases are dashed forward
Become, black arrow meaning represents base replacement in figure, black triangles meaning represents base deletion, contrasted from Fig. 9 that M5 is produced
Two base replacements:T → A and G → A, a base deletion.The PCR primer sequencing peak figure of normal rabbit, M10 and M12 has no set
Peak structure.By M10 and M12 PCR primer sequencing result and normal rabbit MSTN genome alignments, M12 sequencing sequence is found
Consistent with normal rabbit sequence, i.e., M12 rabbits do not find MSTN gene mutations, are the negative rabbit of MSTN gene mutations.
M10 sequencing sequences find that it lacks 136bp, 6 base replacements with normal rabbit MSTN postgenomes, and peak figure is sequenced
Only single base signal, shows that two chromosome mutation situations of M10 MSTN genes are consistent, i.e. M10 is homozygote,
M10 and normal rabbit peak figure contrast situation are shown in Fig. 9, and the signified base of black arrow represents to replace base positions, M12 and normal rabbit
PCR primer sequencing peak figure contrast is visible, and both results are consistent, have no set peak.
Two equipotential bases of fubaritic MSTN genes are sequenced in the young rabbit MSTN Genomic PCR products produced using this technology
The catastrophe of cause.Therefore, young rabbit MSTN Genomic PCR products are inserted into TA carriers, identifies each by TA cloning and sequencings
The mutation type of two allele of MSTN gene mutation rabbits.As a result show, the mutation type of 15 MSTN gene mutation rabbits
There are gene delection, gene insertion, base to replace, mainly based on gene delection, missing base number is between 1~169bp, part
The MSTN gene delections of young rabbit also exist simultaneously base replace or (and) base insertion, 10 MSTN mutation rabbits are obtained altogether, are referred to
Figure 13 and Figure 14.
M1~M6 MSTN Genomic PCR products TA cloning and sequencing results show two dyes of this 6 young rabbit MSTN genes
Colour solid is undergone mutation, and base mutation situation refers to table 2-4, shows mstn-sgRNA1 plasmids designed by rabbit MSTN genes
SgRNA-1 target sites are active, and knock out ultrahigh in efficiency, have reached 100%.Table 2-4 is except M6 Article 2 chromosome
On outer remaining sequence reading frame frameshit caused by target position point mutation of MSTN sequences.Mono- MSTN gene delection 10bp of M1, separately
One missing 2bp, replaces 3 bp, causes the 372nd, 374 cysteine of two articles of allele codings of MSTN of M1 rabbits to lack
Lose, the 375th amino acids of the MSTN gene codes of item chromosome turn into cysteine.A MSTN gene delections for M2 rabbits
52bp so that the 372nd, the 374 cysteine missing of MSTN gene codes, the 361st amino acids turn into cysteine, another
Bar lacks 2bp, replaces 1 bp, also causes the 372nd, the 374 cysteine missing of MSTN gene codes, after frameshift mutation, the
378 amino acids are into cysteine.A MSTN gene delections 26bp for M3 rabbits, another increases 7bp, replaces 1 bp, makes
372nd, 374 cysteine of two articles of allele codings of MSTN of M3 rabbits is lacked.A MSTN gene for M5 rabbits replaces 5
Individual bp, inserts 31 bp, 1 bp of another missing, replaces 1 bp, after translation, the 372nd, 374 of two articles of MSTN gene codes the
Position cysteine is lacked, and the 378th amino acids of the latter's coding turn into cysteine.A MSTN gene delections 10 for M6 rabbits
Individual bp, 9 bp of another missing, the 372nd, 374 cysteine of two articles of MSTN gene codes is lacked, and the latter does not move
Code mutation, has only lacked 3 amino acid, comprising 2 cysteines, the former occurs frameshift mutation, except 2 half Guang ammonia of missing
Acid, the 375th turns into cysteine.Two MSTN genes of M4 lack more, a missing 159bp, replace 1bp, another
Lack 169bp so that the 339th, 340, the 372 of two articles of MSTN gene codes, 374 cysteines are lacked, coded by the latter
The 322nd amino acids turn into cysteine.Mstn-sgRNA1 plasmids are in sgRNA-1 target sites designed by rabbit MSTN genes
For the 372nd cysteine, M1~M6 MSTN Genomic PCR products TA cloning and sequencings result is understood, M1~M6 rabbits
372nd, 374 cysteine of two articles of allele codings of MSTN is lacked, and reaches sgRNA-1 target site purposes of design, again
Due to one of M1, M2, M4, M5, M6 rabbit or two gene frameshift mutations, form new cysteine, but with wild type MSTN
The amino acid sequence of gene code is compared, and the new cysteine of formation is different from being pre-designed the cysteine site of knockout
's.
M8~M11 MSTN Genomic PCR products TA cloning and sequencing results show two dyes of this 4 young rabbit MSTN genes
Colour solid is undergone mutation, and base mutation situation refers to table 2-6, table 2-6 in addition to M9-1 and M11-1 remaining sequence because of target site
Mutation causes reading frame frameshit.M10 rabbits are MSTN gene mutation homozygote rabbits, and two allele of its MSTN genes lack
136bp is lost, 6bp is replaced, causes MSTN gene codes to stop translation to the 290th amino acids, causes remaining 85 bit amino
Acid is lost, including the 309th, 313,339,340,372,374 cysteines.A MSTN gene for M8 rabbits increases 2bp,
Another scarce 2bp, replaces 2bp, cause respectively two articles of gene codes the 340th, 372,374 cysteine missings, the 346th,
351 turn into cysteine and the 340th cysteine missing.12 bp of a MSTN gene delections of M9 rabbits, another is inserted
Enter 1bp, 1 base is replaced, the former causes the 339th of MSTN gene codes the, 340 cysteine missings, the latter causes the
340th, 372,374 cysteine missings.The bp of MSTN gene delections 3 of M11 mono-, another increases 1bp, and the former causes MSTN
The 339th cysteine missing of gene code, the latter causes the 340th cysteine missing.By the ammonia of above sequencing result
From the point of view of base acid translation result, the 309th, 340,372,374 cysteine of two articles of allele codings of M8~M11 rabbits MSTN is equal
There is different degrees of missing, it is active in sgRNA-2 target sites designed by rabbit MSTN genes to show mstn-sgRNA2 plasmids
, and activity is higher, has reached 88.9%.
Data above shows:The art of this patent be used to preparing MSTN gene editings rabbit and design requirement be it is completely the same,
Have the technical effect that feasible, reliable and accurately.
3.2.3 the production performance analysis of this technology
Rabbit is in growth animated period at 2~3 monthly ages, chooses MSTN gene mutations rabbit and the normal negative week old of rabbit 9~14
Growth phase be used for the production performance difference for comparing MSTN gene mutations rabbit and normal negative rabbit.
The build contrast of MSTN gene mutations rabbit and normal rabbit
Collecting part MSTN is mutated the build contrast photo of rabbit and normal rabbit, such as Figure 10, M3, M5, M6 and M10 shoulder and
Buttocks seems broad and solid compared with normal rabbit;Plentiful muscle just can be seen to peel off M9 rabbits in Figure 11.
M9 rabbits, because anaesthetizing improper death, carry out peeling off fur observation, it is seen that its whole body many places muscle groups in 18 week old to it
Knit plentiful, show double-muscled phenotype, rear quarters the muscle plentiful visible M9 of A, C, E and vigorous and graceful arm and shoulder back from Fig. 2-9
Muscle.And D represents the normal negative rabbit that week old is close, its musculature richness substantially, double fleshy exteriors is not showed with M9 differences
Type.
The body weight increase situation of MSTN gene mutations rabbit and normal rabbit in 9~14 week old
In the case where keeping MSTN gene mutations rabbit and normal feminine gender rabbit feeding and management level consistent, from 9 week old by
Weigh the body weight of MSTN gene mutations rabbit and normal negative rabbit day, 14 week old are claimed always.Make a record.MSTN genes are calculated to dash forward
Become the average weight weekly of rabbit and normal negative rabbit.And it is organized into form, such as table 2-6 and 2-7.
Week old body weight table (the unit of table 2-6 MSTN gene mutations rabbit 9~14:G/ is only)
The normal negative week old body weight table (units of rabbit 9~14 of table 2-7:G/ is only)
MSTN gene mutations rabbit is entered with normal negative rabbit in the body weight Zhou Zengliang of 9~14 week old with the softwares of SPSS 21.0
Row systematic variance is analyzed.In the experiment, processing (MSTN gene mutations and normal negative rabbit), sex, week are resolved into total variation
Age (9,10,11,12,13,14 week old), processing and interaction, the interaction of sex and week old, processing and the sex of week old
Between interaction and processing, week old and sex interaction.
Table 2-8 MSTN gene mutations rabbits and the normal negative week old changes of weight variance table of rabbit 9~14
F tables are looked into, work as df1=1, during df2=70, F0.05 (1,60)=4.00, F0.05 (1,80)=3.96;Work as df1=
When 1, df2=70, F0.01 (1,60)=7.08, F0.01 (1,80)=6.96;Work as df1=4, during df2=70, F0.05 (4,
60)=2.53, F0.05 (4,80)=2.49;Work as df1=4, during df2=70, F0.01 (4,60)=3.65, F0.01 (4,80)
=3.56.
The F > F0.01 of processing (MSTN gene mutations and normal negative rabbit) are understood by table 2-8, show MSTN gene mutations
There is pole significant difference in terms of body weight increase with normal negative rabbit;Because 9~14 week old just grow animated period for rabbit, week old
F is naturally larger than F0.01, sex, week old (9,10,11,12,13,14 week old), processing and the interaction of week old, sex and week
The F < F0.05 of the interaction of interaction and processing, week old and sex between interaction, processing and the sex in age, table
Bright, sex, the interaction between week old and processing is not notable, shows that MSTN gene mutations rabbit increases with normal negative rabbit in body weight
The pole significant difference of long side is caused by the factor of MSTN gene mutations.
Multiple range test is carried out and to MSTN bases to MSTN gene mutations rabbit and normal negative rabbit with Duncan methods simultaneously
Because the Different Individual for being mutated rabbit carries out Multiple range test, as a result represented with body weight Zhou Zengliang average values and standard deviation.
The table 2-9 hero week old weight average Zhou Zengchang table (units of rabbit 9~14:G/ is only)
Note:Different lowercase letter indication differences significantly (P<0.05), there is identical lowercase letter indication difference not notable.
Understand that the male rabbit (M2, M6 and M8) of MSTN gene mutations exists with normal negative male rabbit (WT1~WT5) by table 2-9,2-10
There is significant difference in the weight average Zhou Zengliang of 9~14 week old, same MSTN gene mutations doe (M1, M3, M4 and M5) with just
Often there is significant difference in feminine gender doe (WT6~WT10) in the weight average Zhou Zengliang of 9~14 week old, and M10 and normal feminine gender are female
Rabbit (WT6, WT8~WT10) although not notable in the weight average Zhou Zengliang differences of 9~14 week old, weight average Zhou Zengliang's
Average value is above normal negative doe group.Pass through many of the weight average Zhou Zengliang of 9~14 week old of MSTN gene mutation rabbits
Weight is it was found that (being shown in Table 2-11), whether male or female MSTN gene mutation rabbits, the weight average of their 9~14 week old
Zhou Zengliang differences are not notable.
Body weight growth tendency for global analysis MSTN gene mutations rabbit and the Liang Ge colonies of normal negative rabbit and both
Growth variation, while consider influence of the sex to MSTN gene mutations rabbit and normal negative rabbit individual, therefore analysis homology
Other MSTN gene mutations rabbit and the body weight growing state of normal negative rabbit, male and female MSTN bases are sorted out by table 2-7 and 2-8 respectively
Because of mutation rabbit and the negative week old average weight situation of rabbit 9~14 of male and female, disposal data is shown in Table 2-13, and according to table 2-13 data
The rate of body weight gain weekly for calculating MSTN gene mutations rabbit and normal negative rabbit is shown in Table 2-14.
The week old weight average Zhou Zengchang table (units of table 2-10 does 9~14:G/ is only)
Note:Different lowercase letter indication differences significantly (P<0.05), there is identical lowercase letter indication difference not notable.
The week old weight average Zhou Zengchang table (units of table 2-11 MSTN gene mutations rabbit 9~14:G/ is only)
Table2-12 The MSTN gene mutation rabbit s'average weekly growth of
body weight from 9to 14weeks old(unit:g/each)
Note;Different lowercase letter indication differences significantly (P<0.05) identical lowercase or not marking-up matrix, show difference
It is not notable.
Table 2-12 MSTN gene mutations rabbits and normal 9~14 negative week old average weight situation (units:G/ is only)
9~14 week old weight gain rates of the identical sex MSTN gene mutations rabbits of table 2-13 than normal negative rabbit
Note:- represent male MSTN gene mutations rabbit negative rabbit weight gain rate more normal than male
♀+/ ♀-expression female MSTN gene mutations rabbit negative rabbit weight gain rate more normal than female
It can be seen that and compare in same week old section male MSTN gene mutation rabbit average weight numerical value from table 2-12 and Figure 12
Male normal negative rabbit is big, and same female MSTN gene mutation rabbits average weight negative rabbit more normal than female is big, shows same
One growth period MSTN gene mutation rabbit body weight value is bigger than normal negative rabbit.It is can be seen that from table 2-13 in 9~14 week old male
The negative rabbit weightening 13.05~26.74% more normal than male of the average weight of MSTN gene mutation rabbits, female MSTN gene mutations rabbit
Average weight negative rabbit weightening 1.63~17.91% more normal than female, to during 14 week old male and female MSTN gene mutation rabbits it is flat
The equal normal negative rabbit weightening 17.91% and 26.74% of weight ratio male and female.It is can be seen that by Fig. 2-9 and table 2-14 in 9~14 weeks age grades
Section MSTN gene mutations rabbit extends and is continuously increased over time with normal negative rabbit body weight, and the MSTN genes of identical sex
It is mutated rabbit and normally increase trend of all rates of body weight gain of body weight of negative rabbit between 9~14 week old is obvious all the more.
Data above shows:The art of this patent can realize the gene mutation of rabbit MSTN specific sites, the mutation position of design
The achievable muscle of point increases the purpose for accelerating to significantly improve with individual muscle overall content, in terms of husbandry sector and breed improvement
There is higher application value.
SEQUENCE LISTING
<110>Yangzhou University
<120>A kind of edit methods of rabbit MSTN genes
<130>
<160> 14
<170> PatentIn version 3.3
<210> 1
<211> 6980
<212> DNA
<213>New zealand rabbit
<400> 1
atgcaaaaac tgcaaatcta tgtttatatt tacctgttta tgctgatcgt ggctggccca 60
gtggatctaa atgaaaacag tgagcaaaaa gaaaatgtgg aaaaagacgg gctgtgtaat 120
gcatgcactt ggagacaaaa cagtaaatat tcaagaatag aagccataaa gattcaaatc 180
ctcagtaaac ttcgcctgga aacagctcct aacatcagca aagatgctat aagacaactt 240
ttacccaaag ctcctccact ccgggaactg attgatcagt acgacgttca gagggatgac 300
agcagtgatg gctctttgga agatgacgat tatcacgcta cgacggaaac aatcattact 360
atgcctaccg agtgtaagta gtcctattag tgtatgtcaa cagttctgct gactgttgtt 420
ctagtgttta tgggaaacag atctattttc aggctctttt aataagctgt cagcttttat 480
gtaagaagca ggaaagacag tctcttcttt tcaagatttt gtgagaaata tgttgaaact 540
gaaatctgtc acactgtctg tttccttaaa aagctaaaaa gctaaaagat aaaaagcttg 600
cacagcgtta atattatcta gtttaattgg caaatacagc atgcttatgc cttcacagcc 660
tcataccaac cagcaaggcg aggactggca gatactacag caatgttaaa aactcacagg 720
gaattttata agtgcacttg taaaccaaaa tatgcattta ttacaataag cttttcacta 780
gtaataaaga aaggaaggaa cttgctagaa ttttaagctt ctttgagcac tgctgaacac 840
ctccagtgat ttctgttatt ccaaactcct tcacagtgtt ttgtgtgctt cacagattaa 900
aatgtttcct ttcggaggct attacactga ggagcaagaa aatattttaa atactttatg 960
tattagtaag agcaatgacg aaataaaccg tgacttcaaa ttcagaaaat gtctaggaaa 1020
taaacacttc agttgggcaa gttacggctc ctgaagtcct ctcgtacctt gaccatggtg 1080
ctattgttgg cagtactgag tgtgtgtatt tccaagcagg cgtactgctt aataaccttc 1140
gcgaatattt cattcttcat aatggaacga ctattacctg tagtatcaac gttgctcctg 1200
gaagaaaatg tatttcctac aattcctctt tcggtaggct cgaaagaata ctttcacccg 1260
gaaagggaaa cagacacctt gacagagaag gcacggcaag aatgattttg aggccatgtg 1320
tctgtgatct tgctttaaca cagttctttg taagctttaa accggactca aaacagtttc 1380
atagtattgt ttcccttatt cagtaatcag attacagtgc aacaaataat tttcctttaa 1440
gaatttccta ccaaatagtg ctggagtaga ttgaccttat ttatcaatga tttttgaaag 1500
ccaaaagaat ttgttcatgc ttgtctttag aatgacagct cagacataaa ggcaaacttt 1560
tgagacagcc tgaatataac atcaaacttc tctcctaatt acttgcttag ttttgtttct 1620
ttaaaaggat attcctgagc caaaacctcc cggaaatact atattttcta ctgtttccta 1680
aggctcagta agttgctcag tgcgtcttgt ccccaggtaa ttcaggcctg ggggaagggt 1740
tccttcttcc agactgatcg gtacagctgc tccgtcagcg taactactca gattcccaaa 1800
gaattctaag tggatgttcc tccacagtgt ctcttgttct ctctaatcat catcattttc 1860
aaatttcatc cactgctcat tccttcccag aattttcctt agcctgcagt tccttggaag 1920
gggagcagat tcttcacaaa tggttgaaag tacctatgtc taaagaattc tgaaaagcca 1980
gactaattat tttccttgat attttctcgg tattatgaat gaagttttac ctagtatttc 2040
atttacatat gcatgcatta tcccaataga aaaaataccc aactattagt aaggagggat 2100
tttgttaact tattaatgaa aaataatttc aggaactctt gtcttattcg tttatagctg 2160
attttctaat gcaagtggaa ggaaaaccca aatgttgctt ctttaaattt agctctaaaa 2220
tacaatacaa taaagtagta aaggcacaac tatggatata tctgagaccc gtgaagactc 2280
ctacaacagt gtttgtgcaa atcctgaggc tcatcaaacc tatgaaagac ggtacaaggt 2340
atactggaat ccgatctctg aaacttgaca tgaacccagg cactggtatt tggcagagca 2400
ttgatgtgaa gacagtgttg caaaattggc tcaaacaacc tgaatccaac ttaggcattg 2460
aaatcaaagc tttagatgag aatggtcatg atcttgctgt aaccttccca ggaccaggag 2520
aagatgggct ggtaagtgat aactgaaaag aaccctctag taaccttgtt atgtttttgt 2580
tcctaatatg aatgaataaa agtgggaaac aactaccgat ttcctatgct catgagccag 2640
acaaaggtat cttactccaa tggtagccct gtacccaata aaagtaggtg tccaatttca 2700
tatcctatga aaaactccct tgataccctt cgtttgcatg agagtttata aaaacaatta 2760
taccatggtt cttaacttct taagaagttc ttttgaattg agaatgaaat ataaactgct 2820
tttcattgat atgctacatg cttatatgaa taaaatatga actgtatata atgaattcca 2880
gttcataccc caaaaatcag acttttcttt tcctctccaa agggtgccaa atgtgttgac 2940
aagttctggc ttagtataaa gcaagaaaaa aacctaactt tagtctgctt ctttttatct 3000
ctgtctttca aataaaatga aaaaatgtaa agcatcataa tgaaagtaaa atactttcat 3060
ttgtagcaat taactaatta gtataaaaat tatattataa taaatatatt atatttaagg 3120
tccctaatgg taagcatgtt cattacttga tgcacttatc tatggattat tatgtgaaat 3180
accctctaag gacagtttta gtttctaagc cagttagctt ttaccactta acttatttct 3240
aagctggttt agcattcttg cacaagaatt tgacaactaa cttagtatca ggcaaaatag 3300
atggcaatat tttgcatatt ataaaatgaa taaaaactat tttaaaacct agcataaatt 3360
tagggctact cttttggcct atctatgttt ctgtttactt ctgctttcaa aaacttattt 3420
aatatgacaa tattttttca tggacatcta ctgacataat tttcaataga atatacttat 3480
aaaaatgaac attagttatc tttttaatct ctaactggtc ttgtttataa acattatata 3540
ataagtaaat cagatctatt tcaaatgaaa acattcttta aaagactata caattttcta 3600
aatgacttgt ttttcttata tgtattaatt taaatgctat gaattcccaa aaataacatt 3660
ggtttggact gggttaaata acagtaacta tcacatctgt tttcatttta ataaaggaca 3720
aaagctatta tcaattattt aaaaaagcat tcttttttac aagtagtatc ttaatgatca 3780
aagttgatga tatcacagct tttaattatt aaacacgtgg ttaatatggt gcattcttat 3840
ctttccatat aatacagaac aaaatctcaa atgcattaga agactgggag agtgacagta 3900
ctaacaaatg attatatgaa tatgtgaatg aaaacattct gcaacaccta cttttctgaa 3960
tttttctcat aggggttctc ttttcagtcc aatatacaca tcaccacctt catcaatcac 4020
ttagctttct tttcccatta taacttatac actgctggga ggtagctcta gctttaatac 4080
ccaagtttcc ctgagtaaag atccacagat acagaggata gatgactata ctcatccctc 4140
caggaatcat ctcacatatt tggccaacat attgaatcaa cgcatgtgaa gagaaggagc 4200
ccatcttttt cttcctctgc ctctccttcc acctccccct ccctttctcg ccagacagat 4260
tttcaggaca tctatcatgt gctaggcagt tggatactac aactagggac aacaaaaatt 4320
aaaagcacat agaactggcc tcagggggat ttgcattact gctataatct ttgagctatg 4380
aggggaaaat caaaactatt ataaatcaaa tccttagtat gatgcctttt aaatataaag 4440
gtattccaag caaaatgatt catttttctt aaggtaaaaa aagtgcttta gaataaattg 4500
atatacttat cgttctttcc ttttcacaca gaatcccttt ttagaggtca aggtaacgga 4560
cacaccaaaa agatccagaa gagattttgg tcttgactgt gatgagcact caacagaatc 4620
acgatgctgt cgctaccctc taactgtgga ttttgaagct tttggatggg attggattat 4680
tgcgcccaag agatacaagg ccaattactg ctctggagag tgtgaatttg tgtttttaca 4740
aaagtatcct catactcatc ttgtacacca agcaaacccc agaggttcag caggtccttg 4800
ctgtactccc acaaagatgt ctccaattaa tatgctatat tttaatggca aagaacaaat 4860
aatatatggg aaaattccag ccatggtagt agaccgctgt gggtgctcat gagatttgca 4920
tttggttttt aacttcctaa aacatggaag gtcttcccct caacaatttt gaaactgtga 4980
aattatgtac cataggctat aggcctagag tatgctatag tcacttaaac acaagttaca 5040
gtgtatgaac taaaagagag aatacatgca atggttggca tttaaccatc aaaataaatc 5100
atacaatagg aagttttatg atttccagag tttttgaact agaaggagat caaattatat 5160
ttacattcaa ctatgttaca acctaatcaa aaaagtaaag caattctcct tgtgttctga 5220
tgaatcaaag gagtatgtgt taaagtttat ttctttgcag ttttgtttaa tatttacagc 5280
aaaatccatg tatagtattg gtaaaatgca ggactgttat atgccatcat ttgaatcatc 5340
cttaaacact tgaactttta ttttatgata gcatacttgg taagataaaa ttccacaaaa 5400
atagggatgg tctaccatat gcaagtttcc attcctatta tgattggtac catacattaa 5460
caatccatgc caatggtgct aggataatag gctggatgac tggtgttatc aggatttcaa 5520
atataaaaca ttcggtaaaa tgagtttctc cttttttcag gtgcattttc atacatctcc 5580
aaatgaggaa tagattttct ttaatcaaag aaggatcatt tttctagagg tcaactttga 5640
attctgtagc atattggagg aactatacta tattaagagg cagccaaata atattaattt 5700
taaatgaaat tttaagacca cagcctgcct ttgcaacact gcagttttta tgacaaaata 5760
atggaaatga ttatatcaat attgtataaa aagactttaa aacaattgca tttatgtaat 5820
atgtatacaa tattgttttg taaataaatg tctccttttt tatttacttt ggtatatttt 5880
tacactaagg acatttcaaa ttaagtatta aggcacaaaa atgtatcaca gaaaagcaat 5940
tgctcatatt tcagagcaaa ttagcagatt aaatagtggt cttaaaacac catatgttaa 6000
tggttagatg gttatattac aatcatttta tattttttta cattattaac attcactatg 6060
gattcataat gactgtataa tgtgaatgtg gaatttcaat ggtttactgt cattgtattc 6120
aaatctcaac gttccattat tttaatatgt ataatattac taagtatatc aaaatgatta 6180
actccattat ctgaaatgaa gaataataaa ctgatgacat ctcaacaaaa actgttactt 6240
tattttataa tttgataatg aatatatgtc tgcatttgtt tacttctatt ctgtaaattg 6300
ggatttttgt caatcaaatt cattgtactt atgactaggt gaaattattt cttacatcta 6360
atatgtagac actattcaaa ttttattaaa gttttcacat ttttagaaaa atgtgttata 6420
aaattatgtt ataatgatga attctagatt tctgattttc actctattat aagcctaatg 6480
ttttagaaca aaagtttgac ttgagaattt taggtctgtt gctcaagttc tcacaagtaa 6540
aattcctgtt gaattggtct tggtcaagtt tctttacaca tacaaaggca aggactagtt 6600
atatctgttt catttctctt tatcttgacc tgaaaactat ttatatgttt tcataggttc 6660
aatttccaaa tgcattgcag ttggcaagga tatatggtcc tagagttaca agttcttctg 6720
aagccacagg gacacagggg agctacgtct ttttcctagc actaatgata ctggtacctt 6780
catttgagct ttggaagcat taattttcaa attgaatagc aaaaccatta aaaatcactt 6840
agaaatcatt aaatgtgata ttatacataa atatttttga agtgatatct cctctccact 6900
ccccatcact ttagcaactt agttataaag caatgactat tttactgtta gggttcctaa 6960
ataatccaca attaatggca 6980
<210> 2
<211> 20
<212> DNA
<213>Artificial sequence
<400> 2
ccatggtagt agaccgctgt 20
<210> 3
<211> 20
<212> DNA
<213>Artificial sequence
<400> 3
atctttgtgg gagtacagca 20
<210> 4
<211> 18
<212> DNA
<213>Artificial sequence
<400> 4
tgtaaaacga cggccagt 18
<210> 5
<211> 20
<212> DNA
<213>Artificial sequence
<400> 5
tggcaccgag tcggtgcttt 20
<210> 6
<211> 20
<212> DNA
<213>Artificial sequence
<400> 6
attaaccctc actaaaggga 20
<210> 7
<211> 25
<212> DNA
<213>Artificial sequence
<400> 7
aaaaaaagca ccgactcggt gccac 25
<210> 8
<211> 25
<212> DNA
<213>Artificial sequence
<400> 8
tatagccatg gtagtagacc gctgt 25
<210> 9
<211> 25
<212> DNA
<213>Artificial sequence
<400> 9
aaacacagcg gtctactacc atggc 25
<210> 10
<211> 25
<212> DNA
<213>Artificial sequence
<400> 10
tatagatctt tgtgggagta cagca 25
<210> 11
<211> 25
<212> DNA
<213>Artificial sequence
<400> 11
aaactgctgt actcccacaa agatc 25
<210> 12
<211> 82
<212> DNA
<213>Artificial sequence
<400> 12
gttttagagc tagaaatagc aagttaaaat aaggctagtc cgttatcaac ttgaaaaagt 60
ggcaccgagt cggtgctttt tt 82
<210> 13
<211> 18
<212> DNA
<213>Artificial sequence
<400> 13
cttatcgttc tttccttt 18
<210> 14
<211> 18
<212> DNA
<213>Artificial sequence
<400> 14
cctatagcct atggtaca 18
Claims (4)
1. a kind of edit methods of rabbit MSTN genes, it is characterised in that pinpointed using CRISPR/Cas9 in rabbit MSTN locus real
Existing genetic modification;Specifically:
(1) according to the new zealand rabbit MSTN gene target sequences as shown in SEQ ID NO.1, for 4881-4903,4796-4818
Position nucleotide sequence designs sgRNA-1 and sgRNA-2 homing sequence,
(2) 2 kinds of CRISPR/Cas9 bis- are built using homing sequence and the two-in-one plasmid construction kits of YSYCRISPR/Cas9 to close
They are respectively designated as mstn-sgRNA1 and mstn-sgRNA2 by one plasmid
(3) mstn-sgRNA1 and mstn-sgRNA2 plasmids expand sgRNA-1, sgRNA-2 and Cas9 mRNA as PCR respectively
Transcription templates, sgRNA-1, sgRNA-2 and Cas9mRNA are gone out according to transcription templates in-vitro transcription;SgRNA-1 or sgRNA-2 points
Activation new zealand rabbit 4881-4903,4796-4818 nucleosides of MSTN genes are not constituted with Cas9mRNA two-in-one compound
The molecular biology material that acid sequence is mutated and new zealand rabbit MSTN genes are knocked out,
(4) the molecular biology material prepare transgenosis rabbit, the extron 4881- of induction MSTN gene coded sequences the 3rd are utilized
The mutation of 4903 and 4796-4818 nucleotide sequence and missing.
2. according to the method described in claim 1, it is characterised in that the homing sequence of the sgRNA-1 and sgRNA-2 is:
SgRNA-1 homing sequence:5’-CCATGGTAGTAGACCGCTGT-3’
SgRNA-2 homing sequence:5’-ATCTTTGTGGGAGTACAGCA-3’.
3. according to the method described in claim 1, it is characterised in that in step (3) sgRNA-1 and/or sgRNA-2 and
Cas9mRNA presses 1:2-5 ratios are used cooperatively.
4. the method described in claim 1 is applied in lean meat species transgene rabbit breeding.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710191095.3A CN106947780A (en) | 2017-03-28 | 2017-03-28 | A kind of edit methods of rabbit MSTN genes |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710191095.3A CN106947780A (en) | 2017-03-28 | 2017-03-28 | A kind of edit methods of rabbit MSTN genes |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106947780A true CN106947780A (en) | 2017-07-14 |
Family
ID=59473078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710191095.3A Pending CN106947780A (en) | 2017-03-28 | 2017-03-28 | A kind of edit methods of rabbit MSTN genes |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106947780A (en) |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
CN108753837A (en) * | 2018-06-15 | 2018-11-06 | 扬州大学 | The construction method and sgRNA of a kind of hyperlipidemia or rabbit model |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
CN111500581A (en) * | 2020-05-26 | 2020-08-07 | 上海海洋大学 | Molecular breeding method for thickening muscle between silver carps and bighead carps |
CN111549031A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening muscle of grass carp and black carp |
CN111549030A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening crucian muscles |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
CN111560401A (en) * | 2020-05-26 | 2020-08-21 | 上海海洋大学 | Molecular breeding method for thickening interpuscular spurs of erythroculter ilishaeformis and megalobrama amblycephala |
CN111793123A (en) * | 2019-04-08 | 2020-10-20 | 中国农业大学 | Mutant of myostatin MSTN and application thereof |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
CN112442512A (en) * | 2019-08-30 | 2021-03-05 | 华中农业大学 | Gene editing system for Japanese medaka embryos and cells based on tRNA-gRNA-cRNA |
CN112940137A (en) * | 2021-02-08 | 2021-06-11 | 广州安捷生物医学技术有限公司 | PD-1 gene knockout MUC 1-targeted CAR-T cell and preparation method and application thereof |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979585A (en) * | 2010-09-30 | 2011-02-23 | 广西大学 | Method for producing genetically modified rabbit |
CN105671080A (en) * | 2016-03-04 | 2016-06-15 | 内蒙古大学 | CRISPER-Cas9-system-mediated sheep MSTN (myostatin) gene knock-out and exogenous gene site-specific integration method |
CN105821116A (en) * | 2016-04-15 | 2016-08-03 | 扬州大学 | Directional knockout on sheep MSTN gene and detection method for influence thereof on myogenic differentiation |
CN105950625A (en) * | 2016-06-03 | 2016-09-21 | 中国农业科学院北京畜牧兽医研究所 | sgRNA pair for conducting specific recognition on pig MSTN gene promoter and encoding DNA and application thereof |
CN106119283A (en) * | 2016-06-24 | 2016-11-16 | 广西壮族自治区水牛研究所 | A kind of method that the CRISPR of utilization Cas9 targeting knocks out MSTN gene |
-
2017
- 2017-03-28 CN CN201710191095.3A patent/CN106947780A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101979585A (en) * | 2010-09-30 | 2011-02-23 | 广西大学 | Method for producing genetically modified rabbit |
CN105671080A (en) * | 2016-03-04 | 2016-06-15 | 内蒙古大学 | CRISPER-Cas9-system-mediated sheep MSTN (myostatin) gene knock-out and exogenous gene site-specific integration method |
CN105821116A (en) * | 2016-04-15 | 2016-08-03 | 扬州大学 | Directional knockout on sheep MSTN gene and detection method for influence thereof on myogenic differentiation |
CN105950625A (en) * | 2016-06-03 | 2016-09-21 | 中国农业科学院北京畜牧兽医研究所 | sgRNA pair for conducting specific recognition on pig MSTN gene promoter and encoding DNA and application thereof |
CN106119283A (en) * | 2016-06-24 | 2016-11-16 | 广西壮族自治区水牛研究所 | A kind of method that the CRISPR of utilization Cas9 targeting knocks out MSTN gene |
Non-Patent Citations (1)
Title |
---|
张婷等: "CRISPR/Cas9介导兔MSTN基因靶向敲除研究", 《中国畜牧兽医学会兽医产科学分会第十三次学术研讨会论文集》 * |
Cited By (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10323236B2 (en) | 2011-07-22 | 2019-06-18 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US12006520B2 (en) | 2011-07-22 | 2024-06-11 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
US10508298B2 (en) | 2013-08-09 | 2019-12-17 | President And Fellows Of Harvard College | Methods for identifying a target site of a CAS9 nuclease |
US10954548B2 (en) | 2013-08-09 | 2021-03-23 | President And Fellows Of Harvard College | Nuclease profiling system |
US11920181B2 (en) | 2013-08-09 | 2024-03-05 | President And Fellows Of Harvard College | Nuclease profiling system |
US11046948B2 (en) | 2013-08-22 | 2021-06-29 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
US10858639B2 (en) | 2013-09-06 | 2020-12-08 | President And Fellows Of Harvard College | CAS9 variants and uses thereof |
US10912833B2 (en) | 2013-09-06 | 2021-02-09 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US10682410B2 (en) | 2013-09-06 | 2020-06-16 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
US11299755B2 (en) | 2013-09-06 | 2022-04-12 | President And Fellows Of Harvard College | Switchable CAS9 nucleases and uses thereof |
US10597679B2 (en) | 2013-09-06 | 2020-03-24 | President And Fellows Of Harvard College | Switchable Cas9 nucleases and uses thereof |
US9999671B2 (en) | 2013-09-06 | 2018-06-19 | President And Fellows Of Harvard College | Delivery of negatively charged proteins using cationic lipids |
US11053481B2 (en) | 2013-12-12 | 2021-07-06 | President And Fellows Of Harvard College | Fusions of Cas9 domains and nucleic acid-editing domains |
US10465176B2 (en) | 2013-12-12 | 2019-11-05 | President And Fellows Of Harvard College | Cas variants for gene editing |
US11124782B2 (en) | 2013-12-12 | 2021-09-21 | President And Fellows Of Harvard College | Cas variants for gene editing |
US10704062B2 (en) | 2014-07-30 | 2020-07-07 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US11578343B2 (en) | 2014-07-30 | 2023-02-14 | President And Fellows Of Harvard College | CAS9 proteins including ligand-dependent inteins |
US12043852B2 (en) | 2015-10-23 | 2024-07-23 | President And Fellows Of Harvard College | Evolved Cas9 proteins for gene editing |
US11214780B2 (en) | 2015-10-23 | 2022-01-04 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US10167457B2 (en) | 2015-10-23 | 2019-01-01 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
US10947530B2 (en) | 2016-08-03 | 2021-03-16 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11702651B2 (en) | 2016-08-03 | 2023-07-18 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US10113163B2 (en) | 2016-08-03 | 2018-10-30 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11999947B2 (en) | 2016-08-03 | 2024-06-04 | President And Fellows Of Harvard College | Adenosine nucleobase editors and uses thereof |
US11661590B2 (en) | 2016-08-09 | 2023-05-30 | President And Fellows Of Harvard College | Programmable CAS9-recombinase fusion proteins and uses thereof |
US12084663B2 (en) | 2016-08-24 | 2024-09-10 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11542509B2 (en) | 2016-08-24 | 2023-01-03 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
US11306324B2 (en) | 2016-10-14 | 2022-04-19 | President And Fellows Of Harvard College | AAV delivery of nucleobase editors |
US11820969B2 (en) | 2016-12-23 | 2023-11-21 | President And Fellows Of Harvard College | Editing of CCR2 receptor gene to protect against HIV infection |
US10745677B2 (en) | 2016-12-23 | 2020-08-18 | President And Fellows Of Harvard College | Editing of CCR5 receptor gene to protect against HIV infection |
US11898179B2 (en) | 2017-03-09 | 2024-02-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
US11542496B2 (en) | 2017-03-10 | 2023-01-03 | President And Fellows Of Harvard College | Cytosine to guanine base editor |
US11268082B2 (en) | 2017-03-23 | 2022-03-08 | President And Fellows Of Harvard College | Nucleobase editors comprising nucleic acid programmable DNA binding proteins |
US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
US11732274B2 (en) | 2017-07-28 | 2023-08-22 | President And Fellows Of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (PACE) |
US11932884B2 (en) | 2017-08-30 | 2024-03-19 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11319532B2 (en) | 2017-08-30 | 2022-05-03 | President And Fellows Of Harvard College | High efficiency base editors comprising Gam |
US11795443B2 (en) | 2017-10-16 | 2023-10-24 | The Broad Institute, Inc. | Uses of adenosine base editors |
CN108753837B (en) * | 2018-06-15 | 2022-03-29 | 扬州大学 | Construction method of rabbit model with hyperlipidemia or atherosclerosis and sgRNA |
CN108753837A (en) * | 2018-06-15 | 2018-11-06 | 扬州大学 | The construction method and sgRNA of a kind of hyperlipidemia or rabbit model |
US11643652B2 (en) | 2019-03-19 | 2023-05-09 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11795452B2 (en) | 2019-03-19 | 2023-10-24 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
US11447770B1 (en) | 2019-03-19 | 2022-09-20 | The Broad Institute, Inc. | Methods and compositions for prime editing nucleotide sequences |
CN111793123B (en) * | 2019-04-08 | 2022-03-08 | 中国农业大学 | Mutant of myostatin MSTN and application thereof |
CN111793123A (en) * | 2019-04-08 | 2020-10-20 | 中国农业大学 | Mutant of myostatin MSTN and application thereof |
CN112442512A (en) * | 2019-08-30 | 2021-03-05 | 华中农业大学 | Gene editing system for Japanese medaka embryos and cells based on tRNA-gRNA-cRNA |
US11912985B2 (en) | 2020-05-08 | 2024-02-27 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
US12031126B2 (en) | 2020-05-08 | 2024-07-09 | The Broad Institute, Inc. | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
CN111560401A (en) * | 2020-05-26 | 2020-08-21 | 上海海洋大学 | Molecular breeding method for thickening interpuscular spurs of erythroculter ilishaeformis and megalobrama amblycephala |
CN111549030A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening crucian muscles |
CN111549031A (en) * | 2020-05-26 | 2020-08-18 | 上海海洋大学 | Molecular breeding method for thickening muscle of grass carp and black carp |
CN111500581A (en) * | 2020-05-26 | 2020-08-07 | 上海海洋大学 | Molecular breeding method for thickening muscle between silver carps and bighead carps |
CN112940137A (en) * | 2021-02-08 | 2021-06-11 | 广州安捷生物医学技术有限公司 | PD-1 gene knockout MUC 1-targeted CAR-T cell and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106947780A (en) | A kind of edit methods of rabbit MSTN genes | |
EP3122877B1 (en) | Targeted genome editing in zygotes of domestic large animals | |
Elaswad et al. | Microinjection of CRISPR/Cas9 protein into channel catfish, Ictalurus punctatus, embryos for gene editing | |
EP0375406A2 (en) | Transgenic organisms and cells and methods of producing transgenic organisms and cells | |
CN111575319B (en) | Efficient CRISPR RNP and donor DNA co-location mediated gene insertion or replacement method and application thereof | |
CN106086031B (en) | Pig flesh chalone gene editing site and its application | |
CN114214364B (en) | Method for constructing stichopus japonicus gene editing system | |
CN110643636B (en) | Megalobrama amblycephala MSTNa & b gene knockout method and application | |
KR20170058985A (en) | Materials and methods for producing animals with short hair | |
CN106754949B (en) | Pig flesh chalone gene editing site 864-883 and its application | |
Chen | Transgenic fish and aquaculture | |
CN107699571A (en) | A kind of porcine somatostatin gene editing site and its application | |
CN111269877B (en) | Method for polymerization and in-vitro culture of embryo without zona pellucida before implantation | |
CN110938629B (en) | Complete sgRNA for specifically recognizing pig Wip1 gene and application and product thereof | |
CN100445379C (en) | Human alpha-lacto albumin gene transgenic cloned macro domectic animal production method | |
CN113646429A (en) | Method for producing knock-in cell | |
CN111778288A (en) | Method, composition and application for constructing HBV transgenic mouse model | |
Bruter et al. | Usage a CRISPR/Cas9-based for obtaining knockouts of economically significant cattle genes | |
CN1891821B (en) | Production method of animal cell with human lysozyme gene | |
Sánchez-Martín et al. | Generation of Meiotic Mouse Models Using CRISPR/Cas9 Technology | |
CN118389445A (en) | Method for constructing humanized beta-globin gene pig fertilized egg and application thereof | |
CN118064501A (en) | Method for introducing exogenous nucleic acid fragment into bivalve sperm | |
KR20240131508A (en) | Method for generation of hypoallergenic cat using CRISPR/Cas9 system | |
AU2021390998A1 (en) | Transgenic animal having modified myostatin gene | |
US20030150002A1 (en) | Cloning bovines by nuclear transplantation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170714 |